Global mortality associated with 33 bacterial pathogens in 2019: a systematic analysis for the Global Burden of Disease Study 2019
Reducing the burden of death due to infection is an urgent global public health priority. Previous studies have estimated the number of deaths associated with drug-resistant infections and sepsis and found that infections remain a leading cause of death globally. Understanding the global burden of c...
Saved in:
| Published in: | The Lancet (British edition) Vol. 400; no. 10369; pp. 2221 - 2248 |
|---|---|
| Main Authors: | , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , |
| Format: | Journal Article |
| Language: | English |
| Published: |
England
Elsevier Ltd
17.12.2022
Elsevier Limited |
| Subjects: | |
| ISSN: | 0140-6736, 1474-547X, 1474-547X |
| Online Access: | Get full text |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| Abstract | Reducing the burden of death due to infection is an urgent global public health priority. Previous studies have estimated the number of deaths associated with drug-resistant infections and sepsis and found that infections remain a leading cause of death globally. Understanding the global burden of common bacterial pathogens (both susceptible and resistant to antimicrobials) is essential to identify the greatest threats to public health. To our knowledge, this is the first study to present global comprehensive estimates of deaths associated with 33 bacterial pathogens across 11 major infectious syndromes.
We estimated deaths associated with 33 bacterial genera or species across 11 infectious syndromes in 2019 using methods from the Global Burden of Diseases, Injuries, and Risk Factors Study (GBD) 2019, in addition to a subset of the input data described in the Global Burden of Antimicrobial Resistance 2019 study. This study included 343 million individual records or isolates covering 11 361 study-location-years. We used three modelling steps to estimate the number of deaths associated with each pathogen: deaths in which infection had a role, the fraction of deaths due to infection that are attributable to a given infectious syndrome, and the fraction of deaths due to an infectious syndrome that are attributable to a given pathogen. Estimates were produced for all ages and for males and females across 204 countries and territories in 2019. 95% uncertainty intervals (UIs) were calculated for final estimates of deaths and infections associated with the 33 bacterial pathogens following standard GBD methods by taking the 2·5th and 97·5th percentiles across 1000 posterior draws for each quantity of interest.
From an estimated 13·7 million (95% UI 10·9–17·1) infection-related deaths in 2019, there were 7·7 million deaths (5·7–10·2) associated with the 33 bacterial pathogens (both resistant and susceptible to antimicrobials) across the 11 infectious syndromes estimated in this study. We estimated deaths associated with the 33 bacterial pathogens to comprise 13·6% (10·2–18·1) of all global deaths and 56·2% (52·1–60·1) of all sepsis-related deaths in 2019. Five leading pathogens—Staphylococcus aureus, Escherichia coli, Streptococcus pneumoniae, Klebsiella pneumoniae, and Pseudomonas aeruginosa—were responsible for 54·9% (52·9–56·9) of deaths among the investigated bacteria. The deadliest infectious syndromes and pathogens varied by location and age. The age-standardised mortality rate associated with these bacterial pathogens was highest in the sub-Saharan Africa super-region, with 230 deaths (185–285) per 100 000 population, and lowest in the high-income super-region, with 52·2 deaths (37·4–71·5) per 100 000 population. S aureus was the leading bacterial cause of death in 135 countries and was also associated with the most deaths in individuals older than 15 years, globally. Among children younger than 5 years, S pneumoniae was the pathogen associated with the most deaths. In 2019, more than 6 million deaths occurred as a result of three bacterial infectious syndromes, with lower respiratory infections and bloodstream infections each causing more than 2 million deaths and peritoneal and intra-abdominal infections causing more than 1 million deaths.
The 33 bacterial pathogens that we investigated in this study are a substantial source of health loss globally, with considerable variation in their distribution across infectious syndromes and locations. Compared with GBD Level 3 underlying causes of death, deaths associated with these bacteria would rank as the second leading cause of death globally in 2019; hence, they should be considered an urgent priority for intervention within the global health community. Strategies to address the burden of bacterial infections include infection prevention, optimised use of antibiotics, improved capacity for microbiological analysis, vaccine development, and improved and more pervasive use of available vaccines. These estimates can be used to help set priorities for vaccine need, demand, and development.
Bill & Melinda Gates Foundation, Wellcome Trust, and Department of Health and Social Care, using UK aid funding managed by the Fleming Fund. |
|---|---|
| AbstractList | Summary Background Reducing the burden of death due to infection is an urgent global public health priority. Previous studies have estimated the number of deaths associated with drug-resistant infections and sepsis and found that infections remain a leading cause of death globally. Understanding the global burden of common bacterial pathogens (both susceptible and resistant to antimicrobials) is essential to identify the greatest threats to public health. To our knowledge, this is the first study to present global comprehensive estimates of deaths associated with 33 bacterial pathogens across 11 major infectious syndromes. Methods We estimated deaths associated with 33 bacterial genera or species across 11 infectious syndromes in 2019 using methods from the Global Burden of Diseases, Injuries, and Risk Factors Study (GBD) 2019, in addition to a subset of the input data described in the Global Burden of Antimicrobial Resistance 2019 study. This study included 343 million individual records or isolates covering 11 361 study-location-years. We used three modelling steps to estimate the number of deaths associated with each pathogen: deaths in which infection had a role, the fraction of deaths due to infection that are attributable to a given infectious syndrome, and the fraction of deaths due to an infectious syndrome that are attributable to a given pathogen. Estimates were produced for all ages and for males and females across 204 countries and territories in 2019. 95% uncertainty intervals (UIs) were calculated for final estimates of deaths and infections associated with the 33 bacterial pathogens following standard GBD methods by taking the 2·5th and 97·5th percentiles across 1000 posterior draws for each quantity of interest. Findings From an estimated 13·7 million (95% UI 10·9–17·1) infection-related deaths in 2019, there were 7·7 million deaths (5·7–10·2) associated with the 33 bacterial pathogens (both resistant and susceptible to antimicrobials) across the 11 infectious syndromes estimated in this study. We estimated deaths associated with the 33 bacterial pathogens to comprise 13·6% (10·2–18·1) of all global deaths and 56·2% (52·1–60·1) of all sepsis-related deaths in 2019. Five leading pathogens—Staphylococcus aureus, Escherichia coli, Streptococcus pneumoniae, Klebsiella pneumoniae, and Pseudomonas aeruginosa—were responsible for 54·9% (52·9–56·9) of deaths among the investigated bacteria. The deadliest infectious syndromes and pathogens varied by location and age. The age-standardised mortality rate associated with these bacterial pathogens was highest in the sub-Saharan Africa super-region, with 230 deaths (185–285) per 100 000 population, and lowest in the high-income super-region, with 52·2 deaths (37·4–71·5) per 100 000 population. S aureus was the leading bacterial cause of death in 135 countries and was also associated with the most deaths in individuals older than 15 years, globally. Among children younger than 5 years, S pneumoniae was the pathogen associated with the most deaths. In 2019, more than 6 million deaths occurred as a result of three bacterial infectious syndromes, with lower respiratory infections and bloodstream infections each causing more than 2 million deaths and peritoneal and intra-abdominal infections causing more than 1 million deaths. Interpretation The 33 bacterial pathogens that we investigated in this study are a substantial source of health loss globally, with considerable variation in their distribution across infectious syndromes and locations. Compared with GBD Level 3 underlying causes of death, deaths associated with these bacteria would rank as the second leading cause of death globally in 2019; hence, they should be considered an urgent priority for intervention within the global health community. Strategies to address the burden of bacterial infections include infection prevention, optimised use of antibiotics, improved capacity for microbiological analysis, vaccine development, and improved and more pervasive use of available vaccines. These estimates can be used to help set priorities for vaccine need, demand, and development. Funding Bill & Melinda Gates Foundation, Wellcome Trust, and Department of Health and Social Care, using UK aid funding managed by the Fleming Fund. Background Reducing the burden of death due to infection is an urgent global public health priority. Previous studies have estimated the number of deaths associated with drug-resistant infections and sepsis and found that infections remain a leading cause of death globally. Understanding the global burden of common bacterial pathogens (both susceptible and resistant to antimicrobials) is essential to identify the greatest threats to public health. To our knowledge, this is the first study to present global comprehensive estimates of deaths associated with 33 bacterial pathogens across 11 major infectious syndromes. Methods We estimated deaths associated with 33 bacterial genera or species across 11 infectious syndromes in 2019 using methods from the Global Burden of Diseases, Injuries, and Risk Factors Study (GBD) 2019, in addition to a subset of the input data described in the Global Burden of Antimicrobial Resistance 2019 study. This study included 343 million individual records or isolates covering 11 361 study-location-years. We used three modelling steps to estimate the number of deaths associated with each pathogen: deaths in which infection had a role, the fraction of deaths due to infection that are attributable to a given infectious syndrome, and the fraction of deaths due to an infectious syndrome that are attributable to a given pathogen. Estimates were produced for all ages and for males and females across 204 countries and territories in 2019. 95% uncertainty intervals (UIs) were calculated for final estimates of deaths and infections associated with the 33 bacterial pathogens following standard GBD methods by taking the 2.5th and 97.5th percentiles across 1000 posterior draws for each quantity of interest. Findings From an estimated 13.7 million (95% UI 10.9-17.1) infection-related deaths in 2019, there were 7.7 million deaths (5.7-10.2) associated with the 33 bacterial pathogens (both resistant and susceptible to antimicrobials) across the 11 infectious syndromes estimated in this study. We estimated deaths associated with the 33 bacterial pathogens to comprise 13.6% (10.2-18.1) of all global deaths and 56.2% (52.1-60.1) of all sepsis-related deaths in 2019. Five leading pathogens-Staphylococcus aureus, Escherichia coli, Streptococcus pneumoniae, Klebsiella pneumoniae, and Pseudomonas aeruginosa-were responsible for 54.9% (52.9-56.9) of deaths among the investigated bacteria. The deadliest infectious syndromes and pathogens varied by location and age. The age-standardised mortality rate associated with these bacterial pathogens was highest in the sub-Saharan Africa super-region, with 230 deaths (185-285) per 100 000 population, and lowest in the high-income super-region, with 52.2 deaths (37.4-71.5) per 100 000 population. S aureus was the leading bacterial cause of death in 135 countries and was also associated with the most deaths in individuals older than 15 years, globally. Among children younger than 5 years, S pneumoniae was the pathogen associated with the most deaths. In 2019, more than 6 million deaths occurred as a result of three bacterial infectious syndromes, with lower respiratory infections and bloodstream infections each causing more than 2 million deaths and peritoneal and intra-abdominal infections causing more than 1 million deaths. Interpretation The 33 bacterial pathogens that we investigated in this study are a substantial source of health loss globally, with considerable variation in their distribution across infectious syndromes and locations. Compared with GBD Level 3 underlying causes of death, deaths associated with these bacteria would rank as the second leading cause of death globally in 2019; hence, they should be considered an urgent priority for intervention within the global health community. Strategies to address the burden of bacterial infections include infection prevention, optimised use of antibiotics, improved capacity for microbiological analysis, vaccine development, and improved and more pervasive use of available vaccines. These estimates can be used to help set priorities for vaccine need, demand, and development. Copyright (c) 2022 The Author(s). Published by Elsevier Ltd. This is an Open Access article under the CC BY 4.0 license. Reducing the burden of death due to infection is an urgent global public health priority. Previous studies have estimated the number of deaths associated with drug-resistant infections and sepsis and found that infections remain a leading cause of death globally. Understanding the global burden of common bacterial pathogens (both susceptible and resistant to antimicrobials) is essential to identify the greatest threats to public health. To our knowledge, this is the first study to present global comprehensive estimates of deaths associated with 33 bacterial pathogens across 11 major infectious syndromes. We estimated deaths associated with 33 bacterial genera or species across 11 infectious syndromes in 2019 using methods from the Global Burden of Diseases, Injuries, and Risk Factors Study (GBD) 2019, in addition to a subset of the input data described in the Global Burden of Antimicrobial Resistance 2019 study. This study included 343 million individual records or isolates covering 11 361 study-location-years. We used three modelling steps to estimate the number of deaths associated with each pathogen: deaths in which infection had a role, the fraction of deaths due to infection that are attributable to a given infectious syndrome, and the fraction of deaths due to an infectious syndrome that are attributable to a given pathogen. Estimates were produced for all ages and for males and females across 204 countries and territories in 2019. 95% uncertainty intervals (UIs) were calculated for final estimates of deaths and infections associated with the 33 bacterial pathogens following standard GBD methods by taking the 2·5th and 97·5th percentiles across 1000 posterior draws for each quantity of interest. From an estimated 13·7 million (95% UI 10·9–17·1) infection-related deaths in 2019, there were 7·7 million deaths (5·7–10·2) associated with the 33 bacterial pathogens (both resistant and susceptible to antimicrobials) across the 11 infectious syndromes estimated in this study. We estimated deaths associated with the 33 bacterial pathogens to comprise 13·6% (10·2–18·1) of all global deaths and 56·2% (52·1–60·1) of all sepsis-related deaths in 2019. Five leading pathogens—Staphylococcus aureus, Escherichia coli, Streptococcus pneumoniae, Klebsiella pneumoniae, and Pseudomonas aeruginosa—were responsible for 54·9% (52·9–56·9) of deaths among the investigated bacteria. The deadliest infectious syndromes and pathogens varied by location and age. The age-standardised mortality rate associated with these bacterial pathogens was highest in the sub-Saharan Africa super-region, with 230 deaths (185–285) per 100 000 population, and lowest in the high-income super-region, with 52·2 deaths (37·4–71·5) per 100 000 population. S aureus was the leading bacterial cause of death in 135 countries and was also associated with the most deaths in individuals older than 15 years, globally. Among children younger than 5 years, S pneumoniae was the pathogen associated with the most deaths. In 2019, more than 6 million deaths occurred as a result of three bacterial infectious syndromes, with lower respiratory infections and bloodstream infections each causing more than 2 million deaths and peritoneal and intra-abdominal infections causing more than 1 million deaths. The 33 bacterial pathogens that we investigated in this study are a substantial source of health loss globally, with considerable variation in their distribution across infectious syndromes and locations. Compared with GBD Level 3 underlying causes of death, deaths associated with these bacteria would rank as the second leading cause of death globally in 2019; hence, they should be considered an urgent priority for intervention within the global health community. Strategies to address the burden of bacterial infections include infection prevention, optimised use of antibiotics, improved capacity for microbiological analysis, vaccine development, and improved and more pervasive use of available vaccines. These estimates can be used to help set priorities for vaccine need, demand, and development. Bill & Melinda Gates Foundation, Wellcome Trust, and Department of Health and Social Care, using UK aid funding managed by the Fleming Fund. Reducing the burden of death due to infection is an urgent global public health priority. Previous studies have estimated the number of deaths associated with drug-resistant infections and sepsis and found that infections remain a leading cause of death globally. Understanding the global burden of common bacterial pathogens (both susceptible and resistant to antimicrobials) is essential to identify the greatest threats to public health. To our knowledge, this is the first study to present global comprehensive estimates of deaths associated with 33 bacterial pathogens across 11 major infectious syndromes.BACKGROUNDReducing the burden of death due to infection is an urgent global public health priority. Previous studies have estimated the number of deaths associated with drug-resistant infections and sepsis and found that infections remain a leading cause of death globally. Understanding the global burden of common bacterial pathogens (both susceptible and resistant to antimicrobials) is essential to identify the greatest threats to public health. To our knowledge, this is the first study to present global comprehensive estimates of deaths associated with 33 bacterial pathogens across 11 major infectious syndromes.We estimated deaths associated with 33 bacterial genera or species across 11 infectious syndromes in 2019 using methods from the Global Burden of Diseases, Injuries, and Risk Factors Study (GBD) 2019, in addition to a subset of the input data described in the Global Burden of Antimicrobial Resistance 2019 study. This study included 343 million individual records or isolates covering 11 361 study-location-years. We used three modelling steps to estimate the number of deaths associated with each pathogen: deaths in which infection had a role, the fraction of deaths due to infection that are attributable to a given infectious syndrome, and the fraction of deaths due to an infectious syndrome that are attributable to a given pathogen. Estimates were produced for all ages and for males and females across 204 countries and territories in 2019. 95% uncertainty intervals (UIs) were calculated for final estimates of deaths and infections associated with the 33 bacterial pathogens following standard GBD methods by taking the 2·5th and 97·5th percentiles across 1000 posterior draws for each quantity of interest.METHODSWe estimated deaths associated with 33 bacterial genera or species across 11 infectious syndromes in 2019 using methods from the Global Burden of Diseases, Injuries, and Risk Factors Study (GBD) 2019, in addition to a subset of the input data described in the Global Burden of Antimicrobial Resistance 2019 study. This study included 343 million individual records or isolates covering 11 361 study-location-years. We used three modelling steps to estimate the number of deaths associated with each pathogen: deaths in which infection had a role, the fraction of deaths due to infection that are attributable to a given infectious syndrome, and the fraction of deaths due to an infectious syndrome that are attributable to a given pathogen. Estimates were produced for all ages and for males and females across 204 countries and territories in 2019. 95% uncertainty intervals (UIs) were calculated for final estimates of deaths and infections associated with the 33 bacterial pathogens following standard GBD methods by taking the 2·5th and 97·5th percentiles across 1000 posterior draws for each quantity of interest.From an estimated 13·7 million (95% UI 10·9-17·1) infection-related deaths in 2019, there were 7·7 million deaths (5·7-10·2) associated with the 33 bacterial pathogens (both resistant and susceptible to antimicrobials) across the 11 infectious syndromes estimated in this study. We estimated deaths associated with the 33 bacterial pathogens to comprise 13·6% (10·2-18·1) of all global deaths and 56·2% (52·1-60·1) of all sepsis-related deaths in 2019. Five leading pathogens-Staphylococcus aureus, Escherichia coli, Streptococcus pneumoniae, Klebsiella pneumoniae, and Pseudomonas aeruginosa-were responsible for 54·9% (52·9-56·9) of deaths among the investigated bacteria. The deadliest infectious syndromes and pathogens varied by location and age. The age-standardised mortality rate associated with these bacterial pathogens was highest in the sub-Saharan Africa super-region, with 230 deaths (185-285) per 100 000 population, and lowest in the high-income super-region, with 52·2 deaths (37·4-71·5) per 100 000 population. S aureus was the leading bacterial cause of death in 135 countries and was also associated with the most deaths in individuals older than 15 years, globally. Among children younger than 5 years, S pneumoniae was the pathogen associated with the most deaths. In 2019, more than 6 million deaths occurred as a result of three bacterial infectious syndromes, with lower respiratory infections and bloodstream infections each causing more than 2 million deaths and peritoneal and intra-abdominal infections causing more than 1 million deaths.FINDINGSFrom an estimated 13·7 million (95% UI 10·9-17·1) infection-related deaths in 2019, there were 7·7 million deaths (5·7-10·2) associated with the 33 bacterial pathogens (both resistant and susceptible to antimicrobials) across the 11 infectious syndromes estimated in this study. We estimated deaths associated with the 33 bacterial pathogens to comprise 13·6% (10·2-18·1) of all global deaths and 56·2% (52·1-60·1) of all sepsis-related deaths in 2019. Five leading pathogens-Staphylococcus aureus, Escherichia coli, Streptococcus pneumoniae, Klebsiella pneumoniae, and Pseudomonas aeruginosa-were responsible for 54·9% (52·9-56·9) of deaths among the investigated bacteria. The deadliest infectious syndromes and pathogens varied by location and age. The age-standardised mortality rate associated with these bacterial pathogens was highest in the sub-Saharan Africa super-region, with 230 deaths (185-285) per 100 000 population, and lowest in the high-income super-region, with 52·2 deaths (37·4-71·5) per 100 000 population. S aureus was the leading bacterial cause of death in 135 countries and was also associated with the most deaths in individuals older than 15 years, globally. Among children younger than 5 years, S pneumoniae was the pathogen associated with the most deaths. In 2019, more than 6 million deaths occurred as a result of three bacterial infectious syndromes, with lower respiratory infections and bloodstream infections each causing more than 2 million deaths and peritoneal and intra-abdominal infections causing more than 1 million deaths.The 33 bacterial pathogens that we investigated in this study are a substantial source of health loss globally, with considerable variation in their distribution across infectious syndromes and locations. Compared with GBD Level 3 underlying causes of death, deaths associated with these bacteria would rank as the second leading cause of death globally in 2019; hence, they should be considered an urgent priority for intervention within the global health community. Strategies to address the burden of bacterial infections include infection prevention, optimised use of antibiotics, improved capacity for microbiological analysis, vaccine development, and improved and more pervasive use of available vaccines. These estimates can be used to help set priorities for vaccine need, demand, and development.INTERPRETATIONThe 33 bacterial pathogens that we investigated in this study are a substantial source of health loss globally, with considerable variation in their distribution across infectious syndromes and locations. Compared with GBD Level 3 underlying causes of death, deaths associated with these bacteria would rank as the second leading cause of death globally in 2019; hence, they should be considered an urgent priority for intervention within the global health community. Strategies to address the burden of bacterial infections include infection prevention, optimised use of antibiotics, improved capacity for microbiological analysis, vaccine development, and improved and more pervasive use of available vaccines. These estimates can be used to help set priorities for vaccine need, demand, and development.Bill & Melinda Gates Foundation, Wellcome Trust, and Department of Health and Social Care, using UK aid funding managed by the Fleming Fund.FUNDINGBill & Melinda Gates Foundation, Wellcome Trust, and Department of Health and Social Care, using UK aid funding managed by the Fleming Fund. |
| Author | Pardhan, Shahina Dunachie, Susanna J Herteliu, Claudiu Joukar, Farahnaz Matei, Clara N Mohammed, Shafiu Naghavi, Mohsen Kadashetti, Vidya Iradukunda, Arnaud Mohammadian-Hafshejani, Abdollah Padubidri, Jagadish Rao Lal, Dharmesh Kumar Tefera, Belay Negash Raeghi, Saber Chowdhury, Fazle Rabbi Butt, Zahid A Caetano dos Santos, Florentino Luciano Mirmoeeni, Seyyedmohammadsadeq Enyew, Daniel Berhanie Alahdab, Fares Rawaf, Salman Shaikh, Masood Ali Hassan, Shoaib Rashidi, Mohammad-Mahdi Das, Saswati Ilic, Irena M Shirzad-Aski, Hesamaddin Zastrozhin, Mikhail Sergeevich Akbarzadeh-Khiavi, Mostafa Heibati, Behzad Mamo, Galana Ayana Momtazmanesh, Sara Rao, Sowmya J Singh, Surjit Ikuta, Kevin S Charan, Jaykaran Falahi, Shahab Misganaw, Abay Sisay Nuñez-Samudio, Virginia Shrestha, Sunil Szócska, Miklós Krishan, Kewal Afzal, Saira Otstavnov, Nikita Olagunju, Andrew T Ahmed Rashid, Tarik Podder, Indrashis Lasrado, Savita Chu, Dinh-Toi Dora, Bezabih Terefe Filip, Irina Han, Chieh Gershberg Hayoon, Anna Dagnaw, Fentaw Teshome Okonji, Osaretin Christabel K |
| Author_xml | – sequence: 7 givenname: Nicole surname: Davis Weaver fullname: Davis Weaver, Nicole – sequence: 14 givenname: Zeinab surname: Abbasi-Kangevari fullname: Abbasi-Kangevari, Zeinab – sequence: 23 givenname: Juan Manuel surname: Acuna fullname: Acuna, Juan Manuel – sequence: 31 givenname: Zahra Babaei surname: Aghdam fullname: Aghdam, Zahra Babaei – sequence: 32 givenname: Bright Opoku surname: Ahinkorah fullname: Ahinkorah, Bright Opoku – sequence: 33 givenname: Aqeel surname: Ahmad fullname: Ahmad, Aqeel – sequence: 35 givenname: Rizwan surname: Ahmad fullname: Ahmad, Rizwan – sequence: 36 givenname: Sajjad surname: Ahmad fullname: Ahmad, Sajjad – sequence: 37 givenname: Sohail surname: Ahmad fullname: Ahmad, Sohail – sequence: 49 givenname: Ziyad surname: Al-Aly fullname: Al-Aly, Ziyad – sequence: 63 givenname: Edward Kwabena surname: Ameyaw fullname: Ameyaw, Edward Kwabena – sequence: 69 givenname: Dewi surname: Anggraini fullname: Anggraini, Dewi – sequence: 73 givenname: Aleksandr Y surname: Aravkin fullname: Aravkin, Aleksandr Y – sequence: 76 givenname: Anton A surname: Artamonov fullname: Artamonov, Anton A – sequence: 95 givenname: Atif Amin surname: Baig fullname: Baig, Atif Amin – sequence: 97 givenname: Aleksandra surname: Barac fullname: Barac, Aleksandra – sequence: 101 givenname: Amadou surname: Barrow fullname: Barrow, Amadou – sequence: 105 givenname: Neeraj surname: Bedi fullname: Bedi, Neeraj – sequence: 109 givenname: Bharti surname: Bhandari fullname: Bhandari, Bharti – sequence: 114 givenname: Suraj surname: Bhattarai fullname: Bhattarai, Suraj – sequence: 117 givenname: Zahid A surname: Butt fullname: Butt, Zahid A – sequence: 138 givenname: Anna surname: Dastiridou fullname: Dastiridou, Anna – sequence: 150 givenname: Sameer surname: Dhingra fullname: Dhingra, Sameer – sequence: 154 givenname: Milad surname: Dodangeh fullname: Dodangeh, Milad – sequence: 160 givenname: Susanna J surname: Dunachie fullname: Dunachie, Susanna J – sequence: 167 givenname: Muhammed surname: Elhadi fullname: Elhadi, Muhammed – sequence: 169 givenname: Amir surname: Emami fullname: Emami, Amir – sequence: 189 givenname: Abhay Motiramji surname: Gaidhane fullname: Gaidhane, Abhay Motiramji – sequence: 196 givenname: Abdolmajid surname: Gholizadeh fullname: Gholizadeh, Abdolmajid – sequence: 201 givenname: Damitha Asanga surname: Gunawardane fullname: Gunawardane, Damitha Asanga – sequence: 203 givenname: Rajat Das surname: Gupta fullname: Gupta, Rajat Das – sequence: 208 givenname: Parham surname: Habibzadeh fullname: Habibzadeh, Parham – sequence: 211 givenname: Asif surname: Hanif fullname: Hanif, Asif – sequence: 218 givenname: Golnaz surname: Heidari fullname: Heidari, Golnaz – sequence: 221 givenname: Claudiu surname: Herteliu fullname: Herteliu, Claudiu – sequence: 224 givenname: Praveen surname: Hoogar fullname: Hoogar, Praveen – sequence: 228 givenname: Mihaela surname: Hostiuc fullname: Hostiuc, Mihaela – sequence: 236 givenname: Irena M surname: Ilic fullname: Ilic, Irena M – sequence: 239 givenname: Mustapha surname: Immurana fullname: Immurana, Mustapha – sequence: 246 givenname: Mihajlo surname: Jakovljevic fullname: Jakovljevic, Mihajlo – sequence: 253 givenname: Rime surname: Jebai fullname: Jebai, Rime – sequence: 255 givenname: Tamas surname: Joo fullname: Joo, Tamas – sequence: 257 givenname: Farahnaz surname: Joukar fullname: Joukar, Farahnaz – sequence: 261 givenname: Laleh R surname: Kalankesh fullname: Kalankesh, Laleh R – sequence: 280 givenname: Jagdish surname: Khubchandani fullname: Khubchandani, Jagdish – sequence: 282 givenname: Min Seo surname: Kim fullname: Kim, Min Seo – sequence: 288 givenname: Parvaiz A surname: Koul fullname: Koul, Parvaiz A – sequence: 289 givenname: Sindhura Lakshmi surname: Koulmane Laxminarayana fullname: Koulmane Laxminarayana, Sindhura Lakshmi – sequence: 291 givenname: Kewal surname: Krishan fullname: Krishan, Kewal – sequence: 292 givenname: Vijay surname: Krishnamoorthy fullname: Krishnamoorthy, Vijay – sequence: 297 givenname: Hmwe Hmwe surname: Kyu fullname: Kyu, Hmwe Hmwe – sequence: 299 givenname: Judit surname: Lám fullname: Lám, Judit – sequence: 309 givenname: Michael J surname: Loftus fullname: Loftus, Michael J – sequence: 310 givenname: Ayush surname: Lohiya fullname: Lohiya, Ayush – sequence: 311 givenname: László surname: Lorenzovici fullname: Lorenzovici, László – sequence: 313 givenname: Ata surname: Mahmoodpoor fullname: Mahmoodpoor, Ata – sequence: 318 givenname: Alaa surname: Makki fullname: Makki, Alaa – sequence: 319 givenname: Galana Ayana surname: Mamo fullname: Mamo, Galana Ayana – sequence: 323 givenname: Barney surname: McManigal fullname: McManigal, Barney – sequence: 327 givenname: Oliver surname: Mendoza-Cano fullname: Mendoza-Cano, Oliver – sequence: 334 givenname: Shabir Ahmad surname: Mir fullname: Mir, Shabir Ahmad – sequence: 336 givenname: Seyyedmohammadsadeq surname: Mirmoeeni fullname: Mirmoeeni, Seyyedmohammadsadeq – sequence: 344 givenname: Abdollah surname: Mohammadian-Hafshejani fullname: Mohammadian-Hafshejani, Abdollah – sequence: 349 givenname: Sara surname: Momtazmanesh fullname: Momtazmanesh, Sara – sequence: 356 givenname: Haleh surname: Mousavi Isfahani fullname: Mousavi Isfahani, Haleh – sequence: 359 givenname: Sumaira surname: Mubarik fullname: Mubarik, Sumaira – sequence: 360 givenname: Francesk surname: Mulita fullname: Mulita, Francesk – sequence: 361 givenname: Getaneh Baye B surname: Mulu fullname: Mulu, Getaneh Baye B – sequence: 362 givenname: Sandra B surname: Munro fullname: Munro, Sandra B – sequence: 366 givenname: Himanshi surname: Narang fullname: Narang, Himanshi – sequence: 369 givenname: Biswa Prakash surname: Nayak fullname: Nayak, Biswa Prakash – sequence: 379 givenname: Ali surname: Nowroozi fullname: Nowroozi, Ali – sequence: 381 givenname: Jerry John surname: Nutor fullname: Nutor, Jerry John – sequence: 383 givenname: Ogochukwu Janet surname: Nzoputam fullname: Nzoputam, Ogochukwu Janet – sequence: 385 givenname: Rahman Md surname: Obaidur fullname: Obaidur, Rahman Md – sequence: 388 givenname: Osaretin Christabel surname: Okonji fullname: Okonji, Osaretin Christabel – sequence: 401 givenname: Jose L surname: Paredes fullname: Paredes, Jose L – sequence: 403 givenname: Eun-Cheol surname: Park fullname: Park, Eun-Cheol – sequence: 405 givenname: Ashish surname: Pathak fullname: Pathak, Ashish – sequence: 414 givenname: Mario F P surname: Peres fullname: Peres, Mario F P – sequence: 423 givenname: Akila surname: Prashant fullname: Prashant, Akila – sequence: 441 givenname: Azad surname: Rasul fullname: Rasul, Azad – sequence: 451 givenname: Aziz surname: Rezapour fullname: Rezapour, Aziz – sequence: 457 givenname: Umar surname: Saeed fullname: Saeed, Umar – sequence: 458 givenname: Mohsen surname: Safaei fullname: Safaei, Mohsen – sequence: 459 givenname: Azam surname: Safary fullname: Safary, Azam – sequence: 464 givenname: Saina surname: Salahi fullname: Salahi, Saina – sequence: 476 givenname: Subramanian surname: Senthilkumaran fullname: Senthilkumaran, Subramanian – sequence: 493 givenname: Seyed Afshin surname: Shorofi fullname: Shorofi, Seyed Afshin – sequence: 499 givenname: Jasvinder A surname: Singh fullname: Singh, Jasvinder A – sequence: 504 givenname: Valentin Yurievich surname: Skryabin fullname: Skryabin, Valentin Yurievich – sequence: 509 givenname: Chandrashekhar T surname: Sreeramareddy fullname: Sreeramareddy, Chandrashekhar T – sequence: 521 givenname: Vivian Y surname: Tat fullname: Tat, Vivian Y – sequence: 523 givenname: Yibekal Manaye surname: Tefera fullname: Tefera, Yibekal Manaye – sequence: 527 givenname: Arulmani surname: Thiyagarajan fullname: Thiyagarajan, Arulmani – sequence: 530 givenname: Krishna Kishore surname: Umapathi fullname: Umapathi, Krishna Kishore – sequence: 537 givenname: Georgios-Ioannis surname: Verras fullname: Verras, Georgios-Ioannis – sequence: 548 givenname: Dong Keon surname: Yon fullname: Yon, Dong Keon – sequence: 554 givenname: Iman surname: Zare fullname: Zare, Iman – sequence: 560 givenname: Alimuddin surname: Zumla fullname: Zumla, Alimuddin |
| BackLink | https://www.ncbi.nlm.nih.gov/pubmed/36423648$$D View this record in MEDLINE/PubMed https://gup.ub.gu.se/publication/324382$$DView record from Swedish Publication Index (Göteborgs universitet) |
| BookMark | eNqNkUtv1DAURi1URB_wE0CW2JRFwI_EyVAhBAUKUiUWBYmddWPfzLhk4sF2qLLll-N5MIvZlIVlyT7fZ-ueU3I0-AEJecrZS864enXDeMkKVUt1LsQLJnhTFfUDcsLLuiyqsv5xRE72yDE5jfGWMVYqVj0ix1KVIq_mhPy56n0LPV36kKB3aaIQozcOElp659KCSklbMAmDy9gK0sLPcYjUDVQwPntNgcYpJlxCcobCAP0UXaSdDzQtkO7q34_B4kB9Rz-4iBCR3qTRTpuKx-RhB33EJ7v9jHz_9PHb5efi-uvVl8t314WpFE9FbVFKO6ut7KTkEo3Fsm1Y17SKGQDFQJlZnS9UYzivG9tKFICGdZJzXjbyjBTb3niHq7HVq-CWECbtwen5uNL5aD7qiFqKUjYi8-dbfhX8rxFj0ksXDfY9DOjHqEVdsipPWMiMPj9Ab_0Y8izWVJXfZo1aU8921Ngu0e4_8M9GBqotYIKPMWC3RzjTa-t6Y12vlWoh9Ma6rnPu4iBnXMo-_JACuP7e9NttGvPwfzsMOhqHg0HrApqkrXf3Nrw5aDC9G5yB_idO_5H_Czi92AM |
| CitedBy_id | crossref_primary_10_1038_s41564_025_01995_9 crossref_primary_10_1007_s00604_024_06322_3 crossref_primary_10_1021_acs_analchem_5c00240 crossref_primary_10_2147_IDR_S483684 crossref_primary_10_1016_j_ijmm_2024_151643 crossref_primary_10_3390_bios15080551 crossref_primary_10_1016_j_compscitech_2025_111122 crossref_primary_10_1016_j_lanwpc_2024_101282 crossref_primary_10_1016_j_mtcomm_2023_107927 crossref_primary_10_3390_antibiotics12040690 crossref_primary_10_3390_molecules28166018 crossref_primary_10_3389_fcimb_2025_1597700 crossref_primary_10_3389_fpubh_2023_1301685 crossref_primary_10_1038_s41598_025_12384_x crossref_primary_10_1016_S0140_6736_24_00878_X crossref_primary_10_1016_j_mtbio_2025_102040 crossref_primary_10_1016_j_ejmech_2024_116714 crossref_primary_10_1080_21645515_2024_2416763 crossref_primary_10_1038_s41467_023_43759_1 crossref_primary_10_1016_j_biopha_2024_116175 crossref_primary_10_1002_advs_202509796 crossref_primary_10_1016_j_molstruc_2023_136603 crossref_primary_10_15407_bioorganica2023_01_003 crossref_primary_10_1038_s44259_024_00027_6 crossref_primary_10_1007_s00203_024_04096_z crossref_primary_10_1002_adhm_202402323 crossref_primary_10_1016_j_micpath_2024_106608 crossref_primary_10_1017_ash_2025_41 crossref_primary_10_4102_ajlm_v13i1_2519 crossref_primary_10_1016_j_jsamd_2025_100890 crossref_primary_10_1016_j_nbt_2024_05_004 crossref_primary_10_1016_j_mucimm_2025_05_001 crossref_primary_10_1128_iai_00601_24 crossref_primary_10_1093_femsml_uqae014 crossref_primary_10_1007_s11756_025_01873_z crossref_primary_10_1128_jb_00108_25 crossref_primary_10_1002_mba2_70002 crossref_primary_10_1128_mra_00442_24 crossref_primary_10_1016_j_ijbiomac_2024_129753 crossref_primary_10_1055_s_0043_57249 crossref_primary_10_1186_s13073_024_01346_z crossref_primary_10_1039_D4RA01646G crossref_primary_10_1128_spectrum_03087_24 crossref_primary_10_1128_spectrum_03337_24 crossref_primary_10_1016_j_jrras_2023_100790 crossref_primary_10_7554_eLife_88971_3 crossref_primary_10_1016_j_rcsop_2024_100416 crossref_primary_10_1128_spectrum_01306_25 crossref_primary_10_7554_eLife_88971 crossref_primary_10_1021_jacs_5c10219 crossref_primary_10_1080_13696998_2024_2445429 crossref_primary_10_1016_j_inoche_2025_114336 crossref_primary_10_1021_acssensors_5c00038 crossref_primary_10_3389_fpubh_2024_1490401 crossref_primary_10_3390_microorganisms12030450 crossref_primary_10_1128_aac_00482_23 crossref_primary_10_1016_j_micpath_2024_106627 crossref_primary_10_1016_S0140_6736_24_00769_4 crossref_primary_10_1002_wer_11037 crossref_primary_10_1016_j_jare_2025_05_048 crossref_primary_10_1016_j_snb_2024_135296 crossref_primary_10_1186_s12941_024_00740_0 crossref_primary_10_3390_cells13080717 crossref_primary_10_1128_aac_00505_23 crossref_primary_10_1016_j_cmi_2025_02_021 crossref_primary_10_1038_s41467_025_60871_6 crossref_primary_10_1128_jb_00349_25 crossref_primary_10_1093_jac_dkae177 crossref_primary_10_3390_bios13060641 crossref_primary_10_1093_jambio_lxaf120 crossref_primary_10_1016_j_jointm_2025_08_006 crossref_primary_10_1080_08927014_2025_2486250 crossref_primary_10_3390_biom15070980 crossref_primary_10_25259_AJC_183_2025 crossref_primary_10_1016_j_micinf_2024_105334 crossref_primary_10_1371_journal_pone_0329771 crossref_primary_10_1016_j_molstruc_2024_141216 crossref_primary_10_3390_antibiotics13080751 crossref_primary_10_1016_j_micres_2024_127832 crossref_primary_10_3389_fimmu_2024_1486322 crossref_primary_10_1016_j_aca_2023_341614 crossref_primary_10_1002_adhm_202501021 crossref_primary_10_1128_jcm_01079_24 crossref_primary_10_1016_j_mtcomm_2025_111962 crossref_primary_10_3390_antibiotics14050526 crossref_primary_10_3389_fped_2024_1386310 crossref_primary_10_1016_j_eclinm_2025_103397 crossref_primary_10_1016_j_ejmech_2023_115553 crossref_primary_10_1016_j_micinf_2024_105320 crossref_primary_10_1080_10408347_2023_2228902 crossref_primary_10_7759_cureus_87770 crossref_primary_10_1080_14737159_2024_2413556 crossref_primary_10_1093_jac_dkad060 crossref_primary_10_3389_fmicb_2024_1417864 crossref_primary_10_1016_j_intimp_2024_113633 crossref_primary_10_1016_j_lanwpc_2023_100972 crossref_primary_10_3390_ph16010105 crossref_primary_10_1016_S1473_3099_24_00158_0 crossref_primary_10_1016_j_redox_2025_103729 crossref_primary_10_1016_j_jphotobiol_2023_112720 crossref_primary_10_1099_mgen_0_001087 crossref_primary_10_1097_MCG_0000000000001920 crossref_primary_10_1128_spectrum_03199_24 crossref_primary_10_1186_s12879_025_10533_1 crossref_primary_10_3389_fpubh_2025_1642119 crossref_primary_10_1016_j_ijbiomac_2025_145215 crossref_primary_10_1038_s41467_025_61814_x crossref_primary_10_3390_microorganisms12030498 crossref_primary_10_1038_s41591_025_03629_3 crossref_primary_10_1101_gr_279435_124 crossref_primary_10_3389_fvets_2024_1445413 crossref_primary_10_1002_smll_202503536 crossref_primary_10_1128_msphere_00751_23 crossref_primary_10_3389_fmicb_2025_1518051 crossref_primary_10_3390_antibiotics12030610 crossref_primary_10_1097_MD_0000000000044671 crossref_primary_10_1002_eji_202350814 crossref_primary_10_1007_s15010_024_02430_7 crossref_primary_10_1186_s12951_023_02149_x crossref_primary_10_1186_s13765_024_00913_7 crossref_primary_10_1001_jama_2025_12543 crossref_primary_10_1016_j_jconrel_2025_113922 crossref_primary_10_1007_s10495_024_02031_7 crossref_primary_10_3389_fimmu_2024_1401320 crossref_primary_10_1128_cmr_00129_24 crossref_primary_10_3390_pharmaceutics15030720 crossref_primary_10_1016_S0140_6736_23_02350_4 crossref_primary_10_1186_s40249_024_01175_7 crossref_primary_10_1002_adma_202418731 crossref_primary_10_1016_j_bmcl_2023_129517 crossref_primary_10_1016_j_ijbiomac_2024_135360 crossref_primary_10_1016_j_jfp_2024_100442 crossref_primary_10_1002_adfm_202315923 crossref_primary_10_1371_journal_pgen_1011378 crossref_primary_10_1016_j_molmed_2024_02_013 crossref_primary_10_1038_s41598_025_15826_8 crossref_primary_10_1073_pnas_2408800121 crossref_primary_10_1097_JS9_0000000000002668 crossref_primary_10_1093_jac_dkad274 crossref_primary_10_1016_j_ejmech_2025_117920 crossref_primary_10_1016_j_heliyon_2024_e32663 crossref_primary_10_1038_s41541_025_01119_8 crossref_primary_10_1002_smll_202310014 crossref_primary_10_1016_j_mib_2022_102261 crossref_primary_10_1016_j_porgcoat_2025_109651 crossref_primary_10_1021_acs_langmuir_4c05173 crossref_primary_10_1016_j_isci_2025_113015 crossref_primary_10_37349_eds_2025_100897 crossref_primary_10_1016_j_chemosphere_2024_143734 crossref_primary_10_1099_mgen_0_001278 crossref_primary_10_1016_j_isci_2025_112163 crossref_primary_10_1186_s12866_025_03967_9 crossref_primary_10_3390_polym16172409 crossref_primary_10_1088_2632_959X_ad1d02 crossref_primary_10_1111_jvim_70027 crossref_primary_10_1016_j_cej_2025_163305 crossref_primary_10_1099_mgen_0_001280 crossref_primary_10_1016_j_ejmech_2024_116544 crossref_primary_10_1093_jac_dkae355 crossref_primary_10_1186_s12879_024_09004_w crossref_primary_10_3389_fpubh_2023_1216924 crossref_primary_10_1093_jambio_lxad124 crossref_primary_10_1016_j_colsurfb_2023_113657 crossref_primary_10_1016_j_cobme_2023_100471 crossref_primary_10_1016_j_carbpol_2024_122980 crossref_primary_10_1097_INF_0000000000004439 crossref_primary_10_1186_s12934_024_02359_4 crossref_primary_10_3389_fcimb_2025_1689780 crossref_primary_10_1007_s00063_023_01088_7 crossref_primary_10_1021_acsbiomaterials_5c00347 crossref_primary_10_1093_cid_ciad363 crossref_primary_10_1186_s12879_024_09353_6 crossref_primary_10_1128_spectrum_00493_24 crossref_primary_10_1016_j_diagmicrobio_2024_116180 crossref_primary_10_1080_00032719_2023_2293195 crossref_primary_10_3390_coatings14030254 crossref_primary_10_2217_nnm_2023_0243 crossref_primary_10_1111_1751_7915_70161 crossref_primary_10_1016_S2352_4642_24_00140_8 crossref_primary_10_1111_1751_7915_70160 crossref_primary_10_1016_j_ijid_2024_107268 crossref_primary_10_1016_j_survophthal_2025_01_012 crossref_primary_10_1080_15321819_2024_2430344 crossref_primary_10_3389_fphar_2023_1301561 crossref_primary_10_1007_s40121_024_00942_1 crossref_primary_10_3390_diagnostics14030300 crossref_primary_10_1038_s41467_023_43241_y crossref_primary_10_3390_polym16192699 crossref_primary_10_7759_cureus_34153 crossref_primary_10_1080_14787210_2025_2487163 crossref_primary_10_3390_antibiotics13010018 crossref_primary_10_1002_cbdv_202401335 crossref_primary_10_1016_j_envpol_2024_125534 crossref_primary_10_1038_s41598_025_03379_9 crossref_primary_10_3389_fcimb_2023_1209671 crossref_primary_10_1128_spectrum_00511_25 crossref_primary_10_1128_mmbr_00045_22 crossref_primary_10_3390_ph18010092 crossref_primary_10_1016_j_molstruc_2025_141961 crossref_primary_10_1002_jobm_70059 crossref_primary_10_1021_acsomega_5c00867 crossref_primary_10_1002_eji_202250339 crossref_primary_10_7759_cureus_58114 crossref_primary_10_1128_spectrum_00159_25 crossref_primary_10_1186_s13100_025_00351_2 crossref_primary_10_1016_S1473_3099_24_00176_2 crossref_primary_10_1038_s41467_025_59758_3 crossref_primary_10_1016_j_jhazmat_2024_136641 crossref_primary_10_3389_fmicb_2025_1464573 crossref_primary_10_7189_jogh_13_04106 crossref_primary_10_1007_s00431_025_06137_1 crossref_primary_10_1002_prp2_70163 crossref_primary_10_1126_sciadv_adq6399 crossref_primary_10_1016_j_watres_2025_124442 crossref_primary_10_1089_vbz_2023_0066 crossref_primary_10_3389_fbioe_2023_1149588 crossref_primary_10_1186_s12906_025_04880_4 crossref_primary_10_1016_j_vaccine_2024_02_001 crossref_primary_10_1016_j_ccr_2024_216264 crossref_primary_10_1016_j_ccr_2024_216025 crossref_primary_10_1016_S0140_6736_24_00876_6 crossref_primary_10_3390_bios14050210 crossref_primary_10_5492_wjccm_v14_i3_101864 crossref_primary_10_3389_fmicb_2024_1383989 crossref_primary_10_3390_microorganisms11082054 crossref_primary_10_1016_j_jhazmat_2024_136639 crossref_primary_10_3389_fmed_2024_1281418 crossref_primary_10_1016_j_enmm_2025_101059 crossref_primary_10_1371_journal_pgph_0004991 crossref_primary_10_1016_j_ccr_2024_216298 crossref_primary_10_1097_MD_0000000000042084 crossref_primary_10_1093_infdis_jiae437 crossref_primary_10_1016_j_eti_2025_104368 crossref_primary_10_1016_j_genrep_2024_102052 crossref_primary_10_1186_s12866_025_03758_2 crossref_primary_10_1016_j_micpath_2024_107083 crossref_primary_10_1038_s41536_024_00372_0 crossref_primary_10_1084_jem_20240735 crossref_primary_10_3390_microorganisms13092194 crossref_primary_10_1016_j_jhin_2024_03_014 crossref_primary_10_1016_j_jconrel_2025_113907 crossref_primary_10_1002_cmdc_202500283 crossref_primary_10_1002_ctm2_1744 crossref_primary_10_1016_j_vaccine_2025_127455 crossref_primary_10_1016_j_vaccine_2025_127697 crossref_primary_10_1080_1040841X_2025_2473332 crossref_primary_10_1016_j_heliyon_2024_e40076 crossref_primary_10_1093_nar_gkae516 crossref_primary_10_1016_j_envpol_2025_125758 crossref_primary_10_1016_j_cegh_2024_101656 crossref_primary_10_3389_fpubh_2023_1258981 crossref_primary_10_1099_mgen_0_001020 crossref_primary_10_1016_j_carbpol_2025_123928 crossref_primary_10_5492_wjccm_v14_i2_101587 crossref_primary_10_1007_s15010_023_02036_5 crossref_primary_10_1021_acs_jafc_5c04613 crossref_primary_10_3389_fcimb_2024_1446870 crossref_primary_10_1016_j_jim_2024_113786 crossref_primary_10_1093_cid_ciad666 crossref_primary_10_1016_j_bios_2024_116244 crossref_primary_10_1016_j_bpj_2025_03_022 crossref_primary_10_3201_eid3001_AC3001 crossref_primary_10_1038_s41579_025_01169_8 crossref_primary_10_2147_IDR_S431207 crossref_primary_10_1038_s41579_024_01083_5 crossref_primary_10_3389_fmicb_2022_1089140 crossref_primary_10_1093_infdis_jiaf357 crossref_primary_10_3390_antibiotics13090807 crossref_primary_10_1063_5_0277071 crossref_primary_10_1128_spectrum_01289_23 crossref_primary_10_1002_smll_202306960 crossref_primary_10_1080_21505594_2024_2397503 crossref_primary_10_3390_pathogens13060522 crossref_primary_10_1140_epjs_s11734_024_01450_6 crossref_primary_10_1016_j_immuni_2024_05_020 crossref_primary_10_1016_j_colsurfb_2024_113874 crossref_primary_10_1016_j_ijantimicag_2025_107625 crossref_primary_10_1016_j_vaccine_2024_01_004 crossref_primary_10_1016_j_talanta_2024_127158 crossref_primary_10_1186_s12941_024_00703_5 crossref_primary_10_1097_IM9_0000000000000177 crossref_primary_10_3389_fmicb_2025_1528869 crossref_primary_10_1002_advs_202502574 crossref_primary_10_1016_j_molstruc_2025_143056 crossref_primary_10_1016_j_jbc_2024_107282 crossref_primary_10_1007_s00253_025_13440_2 crossref_primary_10_3389_fimmu_2024_1500696 crossref_primary_10_1111_aas_14345 crossref_primary_10_1016_j_revmed_2025_01_007 crossref_primary_10_1007_s11274_025_04414_7 crossref_primary_10_1002_smtd_202400454 crossref_primary_10_1016_j_ntm_2025_100078 crossref_primary_10_1002_bab_2741 crossref_primary_10_1099_mgen_0_001336 crossref_primary_10_3390_ph16030425 crossref_primary_10_1080_22221751_2024_2317915 crossref_primary_10_1016_j_cmi_2024_02_003 crossref_primary_10_1038_s42003_024_07176_4 crossref_primary_10_1016_j_eurpolymj_2024_113511 crossref_primary_10_1016_j_vaccine_2025_126896 crossref_primary_10_1111_ppe_70064 crossref_primary_10_1007_s12223_025_01299_9 crossref_primary_10_1084_jem_20240002 crossref_primary_10_1016_j_matchemphys_2023_128684 crossref_primary_10_3390_biomedicines12010128 crossref_primary_10_3390_molecules29051040 crossref_primary_10_1016_j_ijbiomac_2024_132563 crossref_primary_10_1073_pnas_2423286122 crossref_primary_10_1371_journal_pone_0312305 crossref_primary_10_1002_aoc_70305 crossref_primary_10_1080_1040841X_2024_2429599 crossref_primary_10_1128_aac_00075_24 crossref_primary_10_1016_j_cub_2025_03_055 crossref_primary_10_3390_ijms26041755 crossref_primary_10_3947_ic_2025_0028 crossref_primary_10_1093_ofid_ofae432 crossref_primary_10_1117_1_AP_7_4_046007 crossref_primary_10_1007_s00345_024_05358_7 crossref_primary_10_1186_s12941_025_00811_w crossref_primary_10_1186_s13287_025_04570_5 crossref_primary_10_1016_j_ejmech_2024_117156 crossref_primary_10_3390_ijms26167866 crossref_primary_10_1097_SHK_0000000000002370 crossref_primary_10_1016_j_fbio_2025_106543 crossref_primary_10_1016_j_ijbiomac_2023_127430 crossref_primary_10_3390_microorganisms13081817 crossref_primary_10_3389_fmicb_2025_1592153 crossref_primary_10_1016_j_cej_2023_144597 crossref_primary_10_1021_acsami_5c03839 crossref_primary_10_1016_j_saa_2024_124435 crossref_primary_10_1159_000538002 crossref_primary_10_1186_s12889_024_18990_0 crossref_primary_10_1017_S0950268824001584 crossref_primary_10_7554_eLife_91157 crossref_primary_10_3390_polym15214299 crossref_primary_10_1016_j_pharmthera_2024_108756 crossref_primary_10_1016_j_seppur_2024_128448 crossref_primary_10_3389_fcimb_2023_1257361 crossref_primary_10_1371_journal_ppat_1012495 crossref_primary_10_1007_s11356_024_34355_x crossref_primary_10_7759_cureus_82737 crossref_primary_10_1007_s12088_024_01392_6 crossref_primary_10_1002_advs_202402693 crossref_primary_10_1016_j_jgar_2023_03_003 crossref_primary_10_2147_RMHP_S453686 crossref_primary_10_1021_acsbiomaterials_4c02045 crossref_primary_10_1093_infdis_jiae044 crossref_primary_10_1128_spectrum_00331_24 crossref_primary_10_1016_j_cclet_2025_111055 crossref_primary_10_1128_msystems_00111_25 crossref_primary_10_3389_fmicb_2024_1450085 crossref_primary_10_1371_journal_ppat_1012486 crossref_primary_10_1016_j_micres_2024_128040 crossref_primary_10_1002_mef2_70007 crossref_primary_10_1016_j_ijmm_2025_151645 crossref_primary_10_1002_cbdv_202403042 crossref_primary_10_3390_toxins16060271 crossref_primary_10_1002_adhm_202403800 crossref_primary_10_1007_s11274_025_04323_9 crossref_primary_10_1093_ofid_ofaf338 crossref_primary_10_1007_s42250_023_00830_0 crossref_primary_10_1186_s12866_024_03526_8 crossref_primary_10_1016_j_nmni_2025_101582 crossref_primary_10_1016_S0140_6736_23_01197_2 crossref_primary_10_3390_pharmaceutics15071826 crossref_primary_10_1002_pro_70294 crossref_primary_10_1016_j_saa_2025_126701 crossref_primary_10_1128_iai_00061_25 crossref_primary_10_1093_jacamr_dlae176 crossref_primary_10_3390_v16111711 crossref_primary_10_1093_jacamr_dlae170 crossref_primary_10_3390_antibiotics14090867 crossref_primary_10_1016_j_vaccine_2024_126566 crossref_primary_10_1016_j_tim_2024_12_001 crossref_primary_10_1038_s44328_024_00016_9 crossref_primary_10_3390_antibiotics13090879 crossref_primary_10_1186_s12879_025_11519_9 crossref_primary_10_1007_s00604_024_06342_z crossref_primary_10_1007_s13346_024_01708_5 crossref_primary_10_1186_s13054_024_04990_4 crossref_primary_10_1021_acs_nanolett_4c06179 crossref_primary_10_1128_msphere_00288_23 crossref_primary_10_1016_j_ijantimicag_2025_107470 crossref_primary_10_1002_adma_202407268 crossref_primary_10_1093_femsre_fuad052 crossref_primary_10_3389_fmicb_2023_1223113 crossref_primary_10_3390_ijms252413736 crossref_primary_10_1016_j_colsurfa_2025_137085 crossref_primary_10_1080_17435889_2025_2466419 crossref_primary_10_3390_antibiotics14080827 crossref_primary_10_1080_14787210_2024_2377677 crossref_primary_10_1038_s41467_024_53979_8 crossref_primary_10_1016_j_jmii_2024_11_014 crossref_primary_10_1016_j_ejmech_2024_117187 crossref_primary_10_3390_ijms24032851 crossref_primary_10_1080_21505594_2025_2545558 crossref_primary_10_1128_aac_01176_24 crossref_primary_10_1016_j_virol_2024_110155 crossref_primary_10_1111_febs_70167 crossref_primary_10_3390_coatings14121500 crossref_primary_10_1093_jacamr_dlad060 crossref_primary_10_1016_j_talanta_2024_126435 crossref_primary_10_1093_jambio_lxaf095 crossref_primary_10_3390_antibiotics12111580 crossref_primary_10_1016_j_reactfunctpolym_2025_106295 crossref_primary_10_1038_s41598_025_10519_8 crossref_primary_10_1039_D5TB01635E crossref_primary_10_1186_s40246_023_00563_8 crossref_primary_10_1016_j_advnut_2024_100333 crossref_primary_10_1039_D3NR05557D crossref_primary_10_1021_acsami_3c17134 crossref_primary_10_1038_s41586_024_07626_3 crossref_primary_10_1038_s43856_025_00950_3 crossref_primary_10_1080_17501911_2025_2494983 crossref_primary_10_3389_fimmu_2025_1587018 crossref_primary_10_1016_j_lfs_2023_121993 crossref_primary_10_1371_journal_ppat_1012442 crossref_primary_10_1002_cplu_202400696 crossref_primary_10_1016_j_mtchem_2024_102260 crossref_primary_10_3390_app15031166 crossref_primary_10_1016_j_bioelechem_2024_108785 crossref_primary_10_3389_fpubh_2023_1272562 crossref_primary_10_7554_eLife_91157_3 crossref_primary_10_1016_j_cca_2023_117741 crossref_primary_10_2196_72495 crossref_primary_10_1021_acs_biomac_5c01175 crossref_primary_10_1038_s41429_024_00771_x crossref_primary_10_1128_spectrum_00896_24 crossref_primary_10_1002_cbdv_202500134 crossref_primary_10_1016_j_fbio_2025_106937 crossref_primary_10_3390_antibiotics12030557 crossref_primary_10_1016_j_inoche_2024_113470 crossref_primary_10_1128_mbio_03136_24 crossref_primary_10_3390_ijms241813881 crossref_primary_10_1038_s41598_024_67688_1 crossref_primary_10_1093_cei_uxae074 crossref_primary_10_1038_s41467_024_51144_9 crossref_primary_10_3390_pathogens14080780 crossref_primary_10_1016_j_jmst_2024_01_018 crossref_primary_10_3390_nu15143087 crossref_primary_10_1016_j_cca_2023_117730 crossref_primary_10_2147_IDR_S493575 crossref_primary_10_1007_s12268_024_2339_y crossref_primary_10_1177_20503121241306968 crossref_primary_10_3390_biology12101277 crossref_primary_10_1002_slct_202501928 crossref_primary_10_1016_j_cmi_2024_06_006 crossref_primary_10_2147_IDR_S479043 crossref_primary_10_1002_ppul_27318 crossref_primary_10_1128_cmr_00146_22 crossref_primary_10_1016_j_bios_2025_117835 crossref_primary_10_3389_fcimb_2023_1242702 crossref_primary_10_1016_j_envint_2025_109606 crossref_primary_10_1021_acscentsci_3c01102 crossref_primary_10_3390_antibiotics14040339 crossref_primary_10_1007_s00063_023_01100_0 crossref_primary_10_1186_s12934_024_02418_w crossref_primary_10_1016_j_bmi_2025_100001 crossref_primary_10_3390_gels10060398 crossref_primary_10_1016_j_jfutfo_2025_05_013 crossref_primary_10_1016_j_psj_2025_105859 crossref_primary_10_1021_acssynbio_4c00835 crossref_primary_10_1038_s41591_023_02569_0 crossref_primary_10_1016_j_jpba_2025_116934 crossref_primary_10_1016_j_jbc_2024_107920 crossref_primary_10_1111_pbi_14460 crossref_primary_10_1016_j_jcis_2024_08_129 crossref_primary_10_1128_spectrum_02503_23 crossref_primary_10_7759_cureus_90759 crossref_primary_10_1016_j_jlumin_2025_121190 crossref_primary_10_1128_spectrum_03338_24 crossref_primary_10_1007_s11274_023_03717_x crossref_primary_10_1172_JCI189607 crossref_primary_10_1016_j_bios_2025_117607 crossref_primary_10_1016_j_giant_2025_100366 crossref_primary_10_1128_mra_00656_24 crossref_primary_10_1016_S1473_3099_23_00500_5 crossref_primary_10_1016_j_tim_2025_07_008 crossref_primary_10_14202_vetworld_2023_1803_1814 crossref_primary_10_1016_j_lana_2025_101179 crossref_primary_10_1155_2024_7463899 crossref_primary_10_1038_s41392_023_01553_x crossref_primary_10_1186_s12941_024_00769_1 crossref_primary_10_1038_s41598_025_08523_z crossref_primary_10_3390_bioengineering11121278 crossref_primary_10_3389_fcimb_2025_1635180 crossref_primary_10_1016_S1473_3099_25_00406_2 crossref_primary_10_3390_futurepharmacol5030035 crossref_primary_10_1089_fpd_2024_0043 crossref_primary_10_3389_fimmu_2025_1621095 crossref_primary_10_1021_acsaenm_5c00404 crossref_primary_10_3390_antibiotics12121654 crossref_primary_10_3390_ph18091358 crossref_primary_10_1016_j_heliyon_2024_e24511 crossref_primary_10_1089_phage_2022_0036 crossref_primary_10_1016_j_ijbiomac_2025_145158 crossref_primary_10_1007_s10971_024_06400_1 crossref_primary_10_1016_j_bbadva_2023_100074 crossref_primary_10_3390_pathogens13100847 crossref_primary_10_1002_anbr_202400194 crossref_primary_10_1371_journal_pone_0326353 crossref_primary_10_3389_fmicb_2023_1196957 crossref_primary_10_3390_biom14030320 crossref_primary_10_1016_j_ijbiomac_2024_130611 crossref_primary_10_1016_S2468_1253_24_00224_3 crossref_primary_10_1039_D5NJ00760G crossref_primary_10_1007_s10600_025_04745_9 crossref_primary_10_1016_j_nxnano_2023_100035 crossref_primary_10_1371_journal_ppat_1012992 crossref_primary_10_3389_fcimb_2024_1351618 crossref_primary_10_1093_cid_ciaf037 crossref_primary_10_1016_j_copbio_2023_102969 crossref_primary_10_1002_jcc_27215 crossref_primary_10_1016_j_bbi_2024_04_017 crossref_primary_10_1016_j_aca_2025_344530 crossref_primary_10_3389_fpubh_2024_1411962 crossref_primary_10_34133_bmr_0069 crossref_primary_10_3390_pharmaceutics15051391 crossref_primary_10_3390_antibiotics13111023 crossref_primary_10_1016_j_mtbio_2025_102174 crossref_primary_10_1080_21505594_2025_2543538 crossref_primary_10_1371_journal_pone_0328788 crossref_primary_10_1007_s00792_025_01398_y crossref_primary_10_1093_jacamr_dlaf094 crossref_primary_10_3389_fmed_2025_1566502 crossref_primary_10_1128_spectrum_01685_25 crossref_primary_10_2478_afpuc_2024_0006 crossref_primary_10_3390_antibiotics14050453 crossref_primary_10_3389_fmicb_2023_1202215 crossref_primary_10_1039_D5BM00879D crossref_primary_10_1080_13543776_2024_2348602 crossref_primary_10_3389_fpara_2023_1197956 crossref_primary_10_1007_s42452_023_05612_4 crossref_primary_10_1056_NEJMoa2404991 crossref_primary_10_1002_adhm_202401131 crossref_primary_10_1186_s41479_025_00174_y crossref_primary_10_1128_jb_00109_24 crossref_primary_10_1128_spectrum_03900_23 crossref_primary_10_1093_jac_dkae065 crossref_primary_10_1007_s12274_023_6283_9 crossref_primary_10_1016_j_isci_2024_109690 crossref_primary_10_1016_j_isci_2025_111802 crossref_primary_10_1007_s42770_025_01762_2 crossref_primary_10_1007_s12602_024_10309_0 crossref_primary_10_1038_s41598_023_41281_4 crossref_primary_10_1371_journal_pone_0293562 crossref_primary_10_1016_j_lanmic_2024_100988 crossref_primary_10_1186_s13099_024_00665_1 crossref_primary_10_1007_s15010_024_02326_6 crossref_primary_10_1128_spectrum_03934_23 crossref_primary_10_1016_j_ijfoodmicro_2025_111271 crossref_primary_10_3389_fimmu_2024_1450486 crossref_primary_10_1080_00397911_2025_2535655 crossref_primary_10_3389_fmicb_2022_1041847 crossref_primary_10_1016_j_watres_2025_124391 crossref_primary_10_1016_j_cej_2025_166078 crossref_primary_10_1016_j_idh_2025_02_002 crossref_primary_10_1128_aac_01669_23 crossref_primary_10_3390_antibiotics13020176 crossref_primary_10_3390_antibiotics13020170 crossref_primary_10_1093_infdis_jiad408 crossref_primary_10_1016_j_vaccine_2025_127182 crossref_primary_10_3390_ijms26094211 crossref_primary_10_1016_j_vaccine_2025_127185 crossref_primary_10_1016_j_mser_2023_100715 crossref_primary_10_1099_mgen_0_001187 crossref_primary_10_1186_s40779_024_00581_0 crossref_primary_10_1186_s12985_024_02513_9 crossref_primary_10_1128_iai_00133_24 crossref_primary_10_1128_spectrum_00277_25 crossref_primary_10_1021_acsptsci_4c00183 crossref_primary_10_1016_j_heha_2025_100135 crossref_primary_10_1128_aac_00426_23 crossref_primary_10_1016_j_jcis_2024_06_218 crossref_primary_10_1038_s41598_025_00449_w crossref_primary_10_1039_D5MH01132A crossref_primary_10_1097_QCO_0000000000000989 crossref_primary_10_1080_21645515_2024_2440959 crossref_primary_10_3390_pharmaceutics16091201 crossref_primary_10_3389_fcimb_2025_1584777 crossref_primary_10_1016_j_compbiolchem_2024_108266 crossref_primary_10_1016_j_jpba_2023_115319 crossref_primary_10_1128_msphere_00613_24 crossref_primary_10_1016_j_jiac_2024_02_007 crossref_primary_10_3390_ijms25020735 crossref_primary_10_3389_fimmu_2024_1392456 crossref_primary_10_1007_s40121_023_00911_0 crossref_primary_10_3390_antibiotics13020159 crossref_primary_10_1001_jamapediatrics_2024_2697 crossref_primary_10_1093_cid_ciae138 crossref_primary_10_3390_antibiotics12030501 crossref_primary_10_1021_acs_langmuir_4c05021 crossref_primary_10_1038_s41467_025_56460_2 crossref_primary_10_1126_science_adi0908 crossref_primary_10_1016_j_dib_2023_109704 crossref_primary_10_1016_S0140_6736_24_01019_5 crossref_primary_10_1128_aac_01361_23 crossref_primary_10_3389_fcimb_2024_1467607 crossref_primary_10_1007_s42452_025_07252_2 crossref_primary_10_3389_fimmu_2023_1268804 crossref_primary_10_1016_j_jddst_2025_106952 crossref_primary_10_1016_j_micinf_2024_105426 crossref_primary_10_1016_j_jenvman_2023_119266 crossref_primary_10_3390_antibiotics13090893 crossref_primary_10_1002_pdi_2480 crossref_primary_10_1002_sstr_202400370 crossref_primary_10_1038_s41467_025_61047_y crossref_primary_10_1021_acs_jmedchem_4c02564 crossref_primary_10_1128_aac_00801_25 crossref_primary_10_3390_ijms24065831 crossref_primary_10_1002_adhm_202405300 crossref_primary_10_1002_advs_202417498 crossref_primary_10_1039_D5SM00595G crossref_primary_10_1016_j_scitotenv_2025_178959 crossref_primary_10_1016_j_watcyc_2024_06_004 crossref_primary_10_1128_spectrum_01366_24 crossref_primary_10_1128_cmr_00106_24 crossref_primary_10_1007_s10754_024_09369_0 crossref_primary_10_1016_j_vaccine_2025_127145 crossref_primary_10_1016_j_ajic_2025_08_009 crossref_primary_10_1016_j_psj_2023_103125 crossref_primary_10_1093_jac_dkae248 crossref_primary_10_1186_s12645_023_00226_2 crossref_primary_10_1016_j_mtbio_2025_101912 crossref_primary_10_1093_jac_dkae245 crossref_primary_10_1016_j_ijbiomac_2025_143138 crossref_primary_10_1002_EXP_20230087 crossref_primary_10_1093_cid_ciae589 crossref_primary_10_1016_j_cej_2025_165603 crossref_primary_10_1016_j_microb_2025_100347 crossref_primary_10_3389_fmicb_2025_1593674 crossref_primary_10_1038_s41467_025_58772_9 crossref_primary_10_1016_j_vaccine_2025_127398 crossref_primary_10_1016_j_micres_2024_127987 crossref_primary_10_1007_s00134_024_07381_z crossref_primary_10_1016_j_celrep_2025_115369 crossref_primary_10_1016_j_cej_2025_162334 crossref_primary_10_1186_s13287_024_04019_1 crossref_primary_10_1038_s41598_024_70144_9 crossref_primary_10_1016_S2352_4642_23_00295_X crossref_primary_10_3201_eid3101_241012 crossref_primary_10_1093_cid_ciae338 crossref_primary_10_1097_INF_0000000000004318 crossref_primary_10_1016_j_foodcont_2024_111086 crossref_primary_10_1128_jcm_01154_22 crossref_primary_10_1093_cid_ciad481 crossref_primary_10_3389_fmicb_2022_1032753 crossref_primary_10_1016_j_jcis_2023_04_149 crossref_primary_10_12688_f1000research_146952_1 crossref_primary_10_12688_f1000research_146952_2 crossref_primary_10_3389_fmolb_2023_1238509 crossref_primary_10_1038_s41579_023_00936_9 crossref_primary_10_1128_jb_00171_23 crossref_primary_10_3389_fmicb_2023_1260196 crossref_primary_10_1016_j_jphotobiol_2023_112815 crossref_primary_10_1186_s12879_024_09236_w crossref_primary_10_1016_j_heliyon_2024_e35802 crossref_primary_10_1172_JCI168450 crossref_primary_10_1002_adhm_202405103 crossref_primary_10_12998_wjcc_v11_i17_4026 crossref_primary_10_1007_s10482_024_01944_2 crossref_primary_10_1016_j_nanoen_2024_109287 crossref_primary_10_1056_NEJMe2414037 crossref_primary_10_1186_s12903_025_06217_6 crossref_primary_10_1016_j_jes_2024_09_026 crossref_primary_10_3390_nano13202775 crossref_primary_10_3390_microorganisms13092059 crossref_primary_10_1002_adhm_202301375 crossref_primary_10_1007_s10853_024_10351_x crossref_primary_10_1038_s41467_025_58676_8 crossref_primary_10_1128_aac_00057_24 crossref_primary_10_3390_microorganisms12112336 crossref_primary_10_1136_openhrt_2025_003241 crossref_primary_10_1021_acsinfecdis_5c00109 crossref_primary_10_1099_jmm_0_002014 crossref_primary_10_3892_ijmm_2025_5614 crossref_primary_10_1002_smsc_202400412 crossref_primary_10_1038_s41541_024_00994_x crossref_primary_10_1172_JCI185824 crossref_primary_10_1016_j_jmrt_2025_07_204 crossref_primary_10_3389_fphar_2025_1540925 crossref_primary_10_3389_fmicb_2025_1619416 crossref_primary_10_1007_s00431_024_05624_1 crossref_primary_10_1186_s13613_024_01415_x crossref_primary_10_1016_j_jointm_2025_03_006 crossref_primary_10_1021_jacs_3c13974 crossref_primary_10_1016_j_ijbiomac_2025_144439 crossref_primary_10_1038_s44259_025_00096_1 crossref_primary_10_1186_s12941_025_00780_0 crossref_primary_10_12688_f1000research_159559_1 crossref_primary_10_1007_s40271_023_00640_z crossref_primary_10_3389_fpubh_2024_1367703 crossref_primary_10_1002_cbdv_202300536 crossref_primary_10_1128_aem_02297_23 crossref_primary_10_1371_journal_pone_0306998 crossref_primary_10_1016_j_lanwpc_2025_101467 crossref_primary_10_1039_D3QM01048A crossref_primary_10_1128_aac_00777_24 crossref_primary_10_1080_21645515_2024_2337987 crossref_primary_10_1099_mgen_0_001122 crossref_primary_10_1016_j_microc_2023_109255 crossref_primary_10_1016_j_tifs_2024_104555 crossref_primary_10_33393_dti_2023_2660 crossref_primary_10_1002_iid3_70062 crossref_primary_10_3389_fcimb_2023_1231253 crossref_primary_10_1002_adma_202309797 crossref_primary_10_1038_s41598_025_87659_4 crossref_primary_10_1016_j_clinthera_2024_05_008 crossref_primary_10_1111_php_14019 crossref_primary_10_1016_j_vaccine_2025_127333 crossref_primary_10_1128_msystems_00198_25 crossref_primary_10_3389_fmicb_2025_1524452 crossref_primary_10_1681_ASN_0000000809 crossref_primary_10_1155_bmri_7676973 crossref_primary_10_1016_j_bioadv_2024_214051 crossref_primary_10_3389_fmicb_2023_1238482 crossref_primary_10_1055_a_2193_5436 crossref_primary_10_1073_pnas_2308029120 crossref_primary_10_1099_mgen_0_001383 crossref_primary_10_1001_jama_2025_4288 crossref_primary_10_1016_j_ijantimicag_2025_107609 crossref_primary_10_1371_journal_pbio_3002040 crossref_primary_10_1002_adma_202411173 crossref_primary_10_1016_j_bmc_2023_117454 crossref_primary_10_1038_s42003_024_07159_5 crossref_primary_10_1039_D5RA02955D crossref_primary_10_3390_biology12050681 crossref_primary_10_29254_2077_4214_2025_2_177_376_382 crossref_primary_10_3390_md21100547 crossref_primary_10_1089_phage_2024_0054 crossref_primary_10_3389_fmicb_2024_1342839 crossref_primary_10_3390_tropicalmed8120506 crossref_primary_10_1016_j_jconrel_2025_02_024 crossref_primary_10_1038_s41587_025_02755_0 crossref_primary_10_1002_cbdv_202401142 crossref_primary_10_1016_j_vaccine_2025_127669 crossref_primary_10_1016_S1875_5364_25_60971_X crossref_primary_10_3390_cryst13040564 crossref_primary_10_1016_j_jinf_2025_106462 crossref_primary_10_1016_j_heliyon_2023_e22610 crossref_primary_10_1186_s12964_023_01233_x crossref_primary_10_1096_fj_202401301R crossref_primary_10_3390_antiox12020248 crossref_primary_10_1128_iai_00126_25 crossref_primary_10_1016_j_eimc_2025_06_005 crossref_primary_10_1016_j_foodcont_2025_111513 crossref_primary_10_1016_j_eurpolymj_2023_112698 crossref_primary_10_1088_1748_605X_ad49f4 crossref_primary_10_3390_pathogens14050474 crossref_primary_10_1016_j_mib_2024_102542 crossref_primary_10_1186_s13756_024_01426_0 crossref_primary_10_1002_ppsc_202300191 crossref_primary_10_1007_s00253_024_13050_4 crossref_primary_10_1016_j_ijantimicag_2024_107202 crossref_primary_10_1016_j_jmii_2024_04_009 crossref_primary_10_1007_s40843_024_3051_y crossref_primary_10_1016_j_heliyon_2024_e27575 crossref_primary_10_1007_s12274_024_6699_x crossref_primary_10_1021_acs_jmedchem_5c00152 crossref_primary_10_1128_cmr_00082_25 crossref_primary_10_1016_j_jddst_2025_107539 crossref_primary_10_1038_s41467_024_52714_7 crossref_primary_10_1002_smtd_202500015 crossref_primary_10_1038_s42003_025_07740_6 crossref_primary_10_1002_cbic_202400548 crossref_primary_10_1002_adma_202402530 crossref_primary_10_1099_mgen_0_001444 crossref_primary_10_1128_msystems_00797_25 crossref_primary_10_1016_j_bioflm_2025_100286 crossref_primary_10_1021_acsbiomaterials_4c02190 crossref_primary_10_2147_IDR_S496299 crossref_primary_10_1002_adfm_202509879 crossref_primary_10_1016_j_jes_2024_05_039 crossref_primary_10_1186_s12941_024_00748_6 crossref_primary_10_1021_acsbiomedchemau_5c00010 crossref_primary_10_1038_s42003_025_08258_7 crossref_primary_10_1039_D5NH00257E crossref_primary_10_3389_fmicb_2023_1277221 crossref_primary_10_1002_eji_202451190 crossref_primary_10_1007_s13205_025_04519_8 crossref_primary_10_1016_j_cmi_2024_11_022 crossref_primary_10_3389_fcimb_2024_1336821 crossref_primary_10_3390_pharmaceutics15061766 crossref_primary_10_3390_polym15173570 crossref_primary_10_3390_ani14030487 crossref_primary_10_3389_fimmu_2024_1380732 crossref_primary_10_3389_fimmu_2025_1549293 crossref_primary_10_1080_14737159_2025_2458467 crossref_primary_10_1093_cid_ciad500 crossref_primary_10_1093_jacamr_dlae023 crossref_primary_10_1177_03000605251363105 crossref_primary_10_1016_j_mtcomm_2025_113330 crossref_primary_10_1128_msystems_00497_23 crossref_primary_10_1056_EVIDoa2400108 crossref_primary_10_1016_j_jmoldx_2024_05_008 crossref_primary_10_1128_cmr_00068_22 crossref_primary_10_3390_antibiotics12020242 crossref_primary_10_1542_peds_2024_066588B crossref_primary_10_1186_s41181_024_00252_4 crossref_primary_10_1007_s11101_025_10152_3 crossref_primary_10_1007_s00203_025_04382_4 crossref_primary_10_1038_s41579_024_01116_z crossref_primary_10_1038_s41598_025_02372_6 crossref_primary_10_1080_17518253_2024_2305142 crossref_primary_10_1073_pnas_2412780121 crossref_primary_10_1128_jb_00059_24 crossref_primary_10_1016_j_ijregi_2025_100623 crossref_primary_10_2807_1560_7917_ES_2025_30_11_2400375 crossref_primary_10_1038_s41598_025_90072_6 crossref_primary_10_1016_j_actbio_2024_08_044 crossref_primary_10_1016_j_cmi_2025_06_032 crossref_primary_10_1093_jacamr_dlaf101 crossref_primary_10_1016_j_isci_2025_112248 crossref_primary_10_1126_scitranslmed_adi3275 crossref_primary_10_1016_j_carbon_2023_118740 crossref_primary_10_36488_cmac_2025_1_54_72 crossref_primary_10_1007_s00253_024_13098_2 crossref_primary_10_1016_j_resmic_2024_104250 crossref_primary_10_1016_j_mtbio_2024_101383 crossref_primary_10_1038_s41598_024_60461_4 crossref_primary_10_3390_app14104277 crossref_primary_10_3389_fcimb_2024_1503892 crossref_primary_10_1093_jacamr_dlae019 crossref_primary_10_1128_msphere_00273_24 crossref_primary_10_3389_fcimb_2025_1631575 crossref_primary_10_1002_marc_202500569 crossref_primary_10_1016_j_ajic_2024_12_018 crossref_primary_10_1016_S0140_6736_22_02424_2 crossref_primary_10_1016_j_ijfoodmicro_2023_110297 crossref_primary_10_3389_fmicb_2024_1464135 crossref_primary_10_1007_s00101_025_01531_8 crossref_primary_10_1128_mbio_00559_25 crossref_primary_10_1097_EC9_0000000000000120 crossref_primary_10_1097_SHK_0000000000002243 crossref_primary_10_1093_ofid_ofae303 crossref_primary_10_7759_cureus_61704 crossref_primary_10_1016_j_ijantimicag_2025_107556 crossref_primary_10_1371_journal_pone_0312440 crossref_primary_10_1016_j_amjmed_2025_01_027 crossref_primary_10_1007_s00284_025_04236_8 crossref_primary_10_1016_j_cca_2025_120530 crossref_primary_10_3390_antibiotics13100987 crossref_primary_10_3390_microorganisms11081951 crossref_primary_10_1016_j_cej_2024_155899 crossref_primary_10_1128_jcm_01276_24 crossref_primary_10_1016_j_bioorg_2023_106813 crossref_primary_10_1007_s12668_025_02143_7 crossref_primary_10_1016_j_omtn_2024_102145 crossref_primary_10_3390_antibiotics14030284 crossref_primary_10_4081_idhm_2025_428 crossref_primary_10_1016_j_jes_2024_06_027 crossref_primary_10_1093_infdis_jiad078 crossref_primary_10_1038_s41467_025_59219_x crossref_primary_10_3389_fcimb_2023_1112229 crossref_primary_10_3389_fphar_2025_1570385 crossref_primary_10_1016_j_ijregi_2024_100381 crossref_primary_10_1128_spectrum_02394_24 crossref_primary_10_1016_j_mimet_2023_106808 crossref_primary_10_1093_femsre_fuae007 crossref_primary_10_1016_j_jaci_2024_12_1078 crossref_primary_10_1016_j_lana_2024_100711 crossref_primary_10_1016_j_molstruc_2025_143317 crossref_primary_10_1161_CIRCRESAHA_124_324764 crossref_primary_10_1136_bmjph_2024_001289 crossref_primary_10_1016_j_nedt_2025_106856 crossref_primary_10_2147_IDR_S425398 crossref_primary_10_1016_j_biochi_2024_12_002 crossref_primary_10_1371_journal_pone_0302400 crossref_primary_10_1007_s00284_024_03980_7 crossref_primary_10_2147_IDR_S426000 crossref_primary_10_1016_j_vaccine_2024_07_025 crossref_primary_10_3390_pathogens13080631 crossref_primary_10_25259_JKSUS_425_2025 crossref_primary_10_1038_s41467_025_56308_9 crossref_primary_10_1038_s44319_025_00510_9 crossref_primary_10_1042_EBC20220222 crossref_primary_10_3389_fcimb_2023_1340135 crossref_primary_10_3389_fmicb_2024_1422574 crossref_primary_10_3389_fphar_2022_1124371 crossref_primary_10_1097_MD_0000000000033607 crossref_primary_10_7759_cureus_77255 crossref_primary_10_1073_pnas_2414315122 crossref_primary_10_1080_13543784_2024_2326028 crossref_primary_10_1016_j_ejmech_2025_117341 crossref_primary_10_1039_D4NR03799E crossref_primary_10_1002_fsn3_4221 crossref_primary_10_1111_1751_7915_14306 crossref_primary_10_1093_infdis_jiaf289 crossref_primary_10_1038_s41598_024_59733_w crossref_primary_10_1186_s43094_024_00622_4 crossref_primary_10_1186_s12879_025_10959_7 crossref_primary_10_1016_j_fitote_2025_106428 crossref_primary_10_1080_17568919_2025_2458459 crossref_primary_10_1016_S1473_3099_24_00588_7 crossref_primary_10_3389_fmicb_2025_1530878 crossref_primary_10_1016_j_jconrel_2023_12_051 crossref_primary_10_1016_j_heliyon_2024_e37534 crossref_primary_10_1021_jacs_4c16627 crossref_primary_10_1016_j_pupt_2024_102316 crossref_primary_10_1088_2043_6262_addd24 crossref_primary_10_1088_1361_6528_ad61ed crossref_primary_10_1093_jacamr_dlae034 crossref_primary_10_3389_fmed_2023_1249030 crossref_primary_10_1128_spectrum_02897_23 crossref_primary_10_1016_j_micres_2025_128231 crossref_primary_10_1002_jev2_70032 crossref_primary_10_1016_j_foodchem_2025_143525 crossref_primary_10_12688_wellcomeopenres_24249_1 crossref_primary_10_1007_s00294_025_01317_w crossref_primary_10_15212_ZOONOSES_2024_0060 crossref_primary_10_1016_j_celrep_2024_114432 crossref_primary_10_1128_spectrum_02583_23 crossref_primary_10_1001_jamanetworkopen_2024_0473 crossref_primary_10_1016_j_tim_2023_11_005 crossref_primary_10_1016_j_jwpe_2023_103780 crossref_primary_10_1016_j_artmed_2024_103008 crossref_primary_10_1099_jmm_0_001724 crossref_primary_10_1016_j_cmi_2023_04_011 crossref_primary_10_3390_vaccines12020115 crossref_primary_10_1002_ddr_22138 crossref_primary_10_1016_j_onehlt_2025_101109 crossref_primary_10_1128_iai_00411_25 crossref_primary_10_1038_s41467_025_62292_x crossref_primary_10_1016_j_celrep_2025_115854 crossref_primary_10_1007_s13346_025_01924_7 crossref_primary_10_1007_s40588_024_00236_7 crossref_primary_10_1002_agt2_666 crossref_primary_10_3389_frai_2024_1336071 crossref_primary_10_1016_j_biomaterials_2025_123236 crossref_primary_10_1002_mbo3_1415 crossref_primary_10_3389_fmicb_2024_1449844 crossref_primary_10_3390_ijms252413688 crossref_primary_10_1016_j_aca_2024_342371 crossref_primary_10_1080_15287394_2025_2453858 crossref_primary_10_1016_j_aca_2025_344611 crossref_primary_10_1016_j_inoche_2024_113599 crossref_primary_10_3390_microorganisms12091782 crossref_primary_10_1016_j_ccr_2024_215769 crossref_primary_10_1016_j_phrs_2025_107581 crossref_primary_10_1016_S0140_6736_24_01867_1 crossref_primary_10_1021_acs_jmedchem_5c01285 crossref_primary_10_1016_j_bioorg_2023_107067 crossref_primary_10_1016_j_envpol_2025_126298 crossref_primary_10_3390_microorganisms13010136 crossref_primary_10_1016_j_bios_2025_117718 crossref_primary_10_1016_j_foodchem_2024_141495 crossref_primary_10_1016_j_mtbio_2025_101495 crossref_primary_10_1038_s41467_024_51374_x crossref_primary_10_1039_D4RA07843H crossref_primary_10_1038_s41564_025_02093_6 crossref_primary_10_1039_D5TB00758E crossref_primary_10_1016_j_ejps_2025_107154 crossref_primary_10_1021_acsami_5c08578 crossref_primary_10_1016_j_talanta_2025_127907 crossref_primary_10_1016_S2352_4642_24_00048_8 crossref_primary_10_1093_evlett_qrae030 crossref_primary_10_1093_jacamr_dlae076 crossref_primary_10_1007_s00203_024_04119_9 crossref_primary_10_1002_mco2_70043 crossref_primary_10_1186_s43094_025_00785_8 crossref_primary_10_1111_1751_7915_14510 crossref_primary_10_1038_s44259_025_00100_8 crossref_primary_10_3390_ijerph20031681 crossref_primary_10_1016_j_pmatsci_2025_101532 crossref_primary_10_1016_j_bios_2024_116340 crossref_primary_10_3389_fimmu_2025_1567584 crossref_primary_10_1038_s41746_024_01350_y crossref_primary_10_1016_j_molstruc_2023_136663 crossref_primary_10_1007_s15010_024_02249_2 |
| Cites_doi | 10.1136/bmj.n71 10.1016/S1473-3099(16)30398-X 10.1016/S0140-6736(09)61204-6 10.1016/S2214-109X(20)30357-0 10.1111/tmi.12331 10.1371/journal.pmed.1003787 10.1016/S0140-6736(17)32152-9 10.1016/S2214-109X(21)00024-3 10.1016/S0140-6736(05)66912-7 10.3389/fmed.2019.00205 10.1016/S0140-6736(20)30925-9 10.1371/journal.pmed.1002056 10.1128/CMR.00072-14 10.1056/NEJMoa1005384 10.1186/s13017-017-0141-6 10.1056/NEJMoa1703058 10.1016/S0140-6736(22)00091-5 10.1097/CCM.0000000000005357 10.1038/s41541-020-00232-0 10.1016/S2214-109X(15)70115-4 10.1111/tmi.12339 10.1016/S2214-109X(18)30247-X 10.1016/j.cmi.2021.05.037 10.1016/S1473-3099(20)30003-7 10.1001/jama.2016.0287 10.1055/s-0029-1202938 10.1016/S2214-109X(21)00442-3 10.1016/S0140-6736(21)02724-0 10.1089/vim.2017.0138 10.1056/NEJMhpr020557 10.1016/S0140-6736(19)32989-7 10.1586/14760584.2015.1040395 10.1016/S1473-3099(21)00449-7 10.1016/S2214-109X(14)70349-3 10.1038/s41570-021-00313-1 |
| ContentType | Journal Article |
| Contributor | Abebe, Getachew Baig, Atif Amin Addo, Isaac Yeboah Athari, Seyyed Shamsadin Bagherieh, Sara Abbasi-Kangevari, Mohsen Wool, Eve E Arulappan, Judie Adnan, Mohammad Areda, Demelash Alahdab, Fares Adnani, Qorinah Estiningtyas Sakilah Ansar, Adnan Andrei, Catalina Liliana Anggraini, Dewi Akbarzadeh-Khiavi, Mostafa Abhari, Amir Parsa Aleman, Alicia V Aldeyab, Mamoon A Al Hamad, Hanadi Aboagye, Richard Gyan Ikuta, Kevin S Ali, Liaqat Ali, Syed Shujait B, Darshan B Ameyaw, Edward Kwabena Atlaw, Daniel Ayana, Tegegn Mulatu Ajami, Marjan Afzal, Saira Attia, Sameh Ahmed, Haroon Ahmed Rashid, Tarik Aali, Amirali Ali, Beriwan Abdulqadir Han, Chieh Gershberg Hayoon, Anna Al-Aly, Ziyad Ayala Quintanilla, Beatriz Paulina Azadnajafabad, Sina Aruleba, Raphael Taiwo Aghdam, Zahra Babaei Abate, Semagn Mekonnen Ausloos, Marcel Alhalaiqa, Fadwa Alhalaiqa Naji Awoke, Tewachew Davis Weaver, Nicole Acuna, Juan Manuel Alhassan, Robert Kaba Barac, Aleksandra Ahmad, Aqeel Aljunid, Syed Mohamed Abbasi-Kangevari, Zeinab Asaduzzaman, Muhammad Adane, Tigist Demssew Alimo |
| Contributor_xml | – sequence: 1 givenname: Kevin S surname: Ikuta fullname: Ikuta, Kevin S – sequence: 2 givenname: Lucien R surname: Swetschinski fullname: Swetschinski, Lucien R – sequence: 3 givenname: Gisela surname: Robles Aguilar fullname: Robles Aguilar, Gisela – sequence: 4 givenname: Fablina surname: Sharara fullname: Sharara, Fablina – sequence: 5 givenname: Tomislav surname: Mestrovic fullname: Mestrovic, Tomislav – sequence: 6 givenname: Authia P surname: Gray fullname: Gray, Authia P – sequence: 7 givenname: Nicole surname: Davis Weaver fullname: Davis Weaver, Nicole – sequence: 8 givenname: Eve E surname: Wool fullname: Wool, Eve E – sequence: 9 givenname: Chieh surname: Han fullname: Han, Chieh – sequence: 10 givenname: Anna surname: Gershberg Hayoon fullname: Gershberg Hayoon, Anna – sequence: 11 givenname: Amirali surname: Aali fullname: Aali, Amirali – sequence: 12 givenname: Semagn Mekonnen surname: Abate fullname: Abate, Semagn Mekonnen – sequence: 13 givenname: Mohsen surname: Abbasi-Kangevari fullname: Abbasi-Kangevari, Mohsen – sequence: 14 givenname: Zeinab surname: Abbasi-Kangevari fullname: Abbasi-Kangevari, Zeinab – sequence: 15 givenname: Sherief surname: Abd-Elsalam fullname: Abd-Elsalam, Sherief – sequence: 16 givenname: Getachew surname: Abebe fullname: Abebe, Getachew – sequence: 17 givenname: Aidin surname: Abedi fullname: Abedi, Aidin – sequence: 18 givenname: Amir Parsa surname: Abhari fullname: Abhari, Amir Parsa – sequence: 19 givenname: Hassan surname: Abidi fullname: Abidi, Hassan – sequence: 20 givenname: Richard Gyan surname: Aboagye fullname: Aboagye, Richard Gyan – sequence: 21 givenname: Abdorrahim surname: Absalan fullname: Absalan, Abdorrahim – sequence: 22 givenname: Hiwa surname: Abubaker Ali fullname: Abubaker Ali, Hiwa – sequence: 23 givenname: Juan Manuel surname: Acuna fullname: Acuna, Juan Manuel – sequence: 24 givenname: Tigist Demssew surname: Adane fullname: Adane, Tigist Demssew – sequence: 25 givenname: Isaac Yeboah surname: Addo fullname: Addo, Isaac Yeboah – sequence: 26 givenname: Oyelola A surname: Adegboye fullname: Adegboye, Oyelola A – sequence: 27 givenname: Mohammad surname: Adnan fullname: Adnan, Mohammad – sequence: 28 givenname: Qorinah Estiningtyas Sakilah surname: Adnani fullname: Adnani, Qorinah Estiningtyas Sakilah – sequence: 29 givenname: Muhammad Sohail surname: Afzal fullname: Afzal, Muhammad Sohail – sequence: 30 givenname: Saira surname: Afzal fullname: Afzal, Saira – sequence: 31 givenname: Zahra Babaei surname: Aghdam fullname: Aghdam, Zahra Babaei – sequence: 32 givenname: Bright Opoku surname: Ahinkorah fullname: Ahinkorah, Bright Opoku – sequence: 33 givenname: Aqeel surname: Ahmad fullname: Ahmad, Aqeel – sequence: 34 givenname: Araz Ramazan surname: Ahmad fullname: Ahmad, Araz Ramazan – sequence: 35 givenname: Rizwan surname: Ahmad fullname: Ahmad, Rizwan – sequence: 36 givenname: Sajjad surname: Ahmad fullname: Ahmad, Sajjad – sequence: 37 givenname: Sohail surname: Ahmad fullname: Ahmad, Sohail – sequence: 38 givenname: Sepideh surname: Ahmadi fullname: Ahmadi, Sepideh – sequence: 39 givenname: Ali surname: Ahmed fullname: Ahmed, Ali – sequence: 40 givenname: Haroon surname: Ahmed fullname: Ahmed, Haroon – sequence: 41 givenname: Jivan Qasim surname: Ahmed fullname: Ahmed, Jivan Qasim – sequence: 42 givenname: Tarik surname: Ahmed Rashid fullname: Ahmed Rashid, Tarik – sequence: 43 givenname: Marjan surname: Ajami fullname: Ajami, Marjan – sequence: 44 givenname: Budi surname: Aji fullname: Aji, Budi – sequence: 45 givenname: Mostafa surname: Akbarzadeh-Khiavi fullname: Akbarzadeh-Khiavi, Mostafa – sequence: 46 givenname: Chisom Joyqueenet surname: Akunna fullname: Akunna, Chisom Joyqueenet – sequence: 47 givenname: Hanadi surname: Al Hamad fullname: Al Hamad, Hanadi – sequence: 48 givenname: Fares surname: Alahdab fullname: Alahdab, Fares – sequence: 49 givenname: Ziyad surname: Al-Aly fullname: Al-Aly, Ziyad – sequence: 50 givenname: Mamoon A surname: Aldeyab fullname: Aldeyab, Mamoon A – sequence: 51 givenname: Alicia V surname: Aleman fullname: Aleman, Alicia V – sequence: 52 givenname: Fadwa Alhalaiqa Naji surname: Alhalaiqa fullname: Alhalaiqa, Fadwa Alhalaiqa Naji – sequence: 53 givenname: Robert Kaba surname: Alhassan fullname: Alhassan, Robert Kaba – sequence: 54 givenname: Beriwan Abdulqadir surname: Ali fullname: Ali, Beriwan Abdulqadir – sequence: 55 givenname: Liaqat surname: Ali fullname: Ali, Liaqat – sequence: 56 givenname: Syed Shujait surname: Ali fullname: Ali, Syed Shujait – sequence: 57 givenname: Yousef surname: Alimohamadi fullname: Alimohamadi, Yousef – sequence: 58 givenname: Vahid surname: Alipour fullname: Alipour, Vahid – sequence: 59 givenname: Atiyeh surname: Alizadeh fullname: Alizadeh, Atiyeh – sequence: 60 givenname: Syed Mohamed surname: Aljunid fullname: Aljunid, Syed Mohamed – sequence: 61 givenname: Kasim surname: Allel fullname: Allel, Kasim – sequence: 62 givenname: Sami surname: Almustanyir fullname: Almustanyir, Sami – sequence: 63 givenname: Edward Kwabena surname: Ameyaw fullname: Ameyaw, Edward Kwabena – sequence: 64 givenname: Arianna Maever L surname: Amit fullname: Amit, Arianna Maever L – sequence: 65 givenname: Nivedita surname: Anandavelane fullname: Anandavelane, Nivedita – sequence: 66 givenname: Robert surname: Ancuceanu fullname: Ancuceanu, Robert – sequence: 67 givenname: Catalina Liliana surname: Andrei fullname: Andrei, Catalina Liliana – sequence: 68 givenname: Tudorel surname: Andrei fullname: Andrei, Tudorel – sequence: 69 givenname: Dewi surname: Anggraini fullname: Anggraini, Dewi – sequence: 70 givenname: Adnan surname: Ansar fullname: Ansar, Adnan – sequence: 71 givenname: Anayochukwu Edward surname: Anyasodor fullname: Anyasodor, Anayochukwu Edward – sequence: 72 givenname: Jalal surname: Arabloo fullname: Arabloo, Jalal – sequence: 73 givenname: Aleksandr Y surname: Aravkin fullname: Aravkin, Aleksandr Y – sequence: 74 givenname: Demelash surname: Areda fullname: Areda, Demelash – sequence: 75 givenname: Timur surname: Aripov fullname: Aripov, Timur – sequence: 76 givenname: Anton A surname: Artamonov fullname: Artamonov, Anton A – sequence: 77 givenname: Judie surname: Arulappan fullname: Arulappan, Judie – sequence: 78 givenname: Raphael Taiwo surname: Aruleba fullname: Aruleba, Raphael Taiwo – sequence: 79 givenname: Muhammad surname: Asaduzzaman fullname: Asaduzzaman, Muhammad – sequence: 80 givenname: Tahira surname: Ashraf fullname: Ashraf, Tahira – sequence: 81 givenname: Seyyed Shamsadin surname: Athari fullname: Athari, Seyyed Shamsadin – sequence: 82 givenname: Daniel surname: Atlaw fullname: Atlaw, Daniel – sequence: 83 givenname: Sameh surname: Attia fullname: Attia, Sameh – sequence: 84 givenname: Marcel surname: Ausloos fullname: Ausloos, Marcel – sequence: 85 givenname: Tewachew surname: Awoke fullname: Awoke, Tewachew – sequence: 86 givenname: Beatriz Paulina surname: Ayala Quintanilla fullname: Ayala Quintanilla, Beatriz Paulina – sequence: 87 givenname: Tegegn Mulatu surname: Ayana fullname: Ayana, Tegegn Mulatu – sequence: 88 givenname: Sina surname: Azadnajafabad fullname: Azadnajafabad, Sina – sequence: 89 givenname: Amirhossein surname: Azari Jafari fullname: Azari Jafari, Amirhossein – sequence: 90 givenname: Darshan B surname: B fullname: B, Darshan B – sequence: 91 givenname: Muhammad surname: Badar fullname: Badar, Muhammad – sequence: 92 givenname: Ashish D surname: Badiye fullname: Badiye, Ashish D – sequence: 93 givenname: Nayereh surname: Baghcheghi fullname: Baghcheghi, Nayereh – sequence: 94 givenname: Sara surname: Bagherieh fullname: Bagherieh, Sara – sequence: 95 givenname: Atif Amin surname: Baig fullname: Baig, Atif Amin – sequence: 96 givenname: Indrajit surname: Banerjee fullname: Banerjee, Indrajit – sequence: 97 givenname: Aleksandra surname: Barac fullname: Barac, Aleksandra – sequence: 98 givenname: Mainak surname: Bardhan fullname: Bardhan, Mainak – sequence: 99 givenname: Francesco surname: Barone-Adesi fullname: Barone-Adesi, Francesco – sequence: 100 givenname: Hiba Jawdat surname: Barqawi fullname: Barqawi, Hiba Jawdat |
| Copyright | 2022 The Author(s). Published by Elsevier Ltd. This is an Open Access article under the CC BY 4.0 license Copyright © 2022 The Author(s). Published by Elsevier Ltd. This is an Open Access article under the CC BY 4.0 license. Published by Elsevier Ltd.. All rights reserved. 2022. The Author(s). Published by Elsevier Ltd. This is an Open Access article under the CC BY 4.0 license. This work is published under https://creativecommons.org/licenses/by/3.0/ (theLicense”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. |
| Copyright_xml | – notice: 2022 The Author(s). Published by Elsevier Ltd. This is an Open Access article under the CC BY 4.0 license – notice: Copyright © 2022 The Author(s). Published by Elsevier Ltd. This is an Open Access article under the CC BY 4.0 license. Published by Elsevier Ltd.. All rights reserved. – notice: 2022. The Author(s). Published by Elsevier Ltd. This is an Open Access article under the CC BY 4.0 license. This work is published under https://creativecommons.org/licenses/by/3.0/ (theLicense”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. |
| CorporateAuthor | GBD 2019 Antimicrobial Resistance Collaborators |
| CorporateAuthor_xml | – name: GBD 2019 Antimicrobial Resistance Collaborators |
| DBID | 6I. AAFTH AAYXX CITATION CGR CUY CVF ECM EIF NPM 3V. 7QL 7QP 7RV 7TK 7U7 7U9 7X7 7XB 88A 88C 88E 88G 88I 8AF 8AO 8C1 8C2 8FE 8FH 8FI 8FJ 8FK 8G5 ABUWG AEUYN AFKRA AN0 ASE AZQEC BBNVY BEC BENPR BHPHI C1K CCPQU DWQXO FPQ FYUFA GHDGH GNUQQ GUQSH H94 HCIFZ K6X K9- K9. KB0 KB~ LK8 M0R M0S M0T M1P M2M M2O M2P M7N M7P MBDVC NAPCQ PHGZM PHGZT PJZUB PKEHL PPXIY PQEST PQGLB PQQKQ PQUKI PSYQQ Q9U S0X 7X8 ADTPV AOWAS F1U |
| DOI | 10.1016/S0140-6736(22)02185-7 |
| DatabaseName | ScienceDirect Open Access Titles Elsevier:ScienceDirect:Open Access CrossRef Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed ProQuest Central (Corporate) Bacteriology Abstracts (Microbiology B) Calcium & Calcified Tissue Abstracts Nursing & Allied Health Database Neurosciences Abstracts Toxicology Abstracts Virology and AIDS Abstracts ProQuest Health & Medical Collection ProQuest Central (purchase pre-March 2016) Biology Database (Alumni Edition) Healthcare Administration Database (Alumni) Medical Database (Alumni Edition) Psychology Database (Alumni) Science Database (Alumni Edition) STEM Database ProQuest Pharma Collection Public Health Database Lancet Titles ProQuest SciTech Collection ProQuest Natural Science Collection Hospital Premium Collection Hospital Premium Collection (Alumni Edition) ProQuest Central (Alumni) (purchase pre-March 2016) Research Library (Alumni Edition) ProQuest Central (Alumni) ProQuest One Sustainability (subscription) ProQuest Central UK/Ireland British Nursing Database British Nursing Index ProQuest Central Essentials Biological Science Collection ProQuest eLibrary (NC LIVE) ProQuest Central Natural Science Collection Environmental Sciences and Pollution Management ProQuest One Community College ProQuest Central British Nursing Index (BNI) (1985 to Present) Health Research Premium Collection Health Research Premium Collection (Alumni) ProQuest Central Student Research Library Prep AIDS and Cancer Research Abstracts SciTech Premium Collection British Nursing Index Consumer Health Database ProQuest Health & Medical Complete (Alumni) Nursing & Allied Health Database (Alumni Edition) ProQuest Newsstand Professional Biological Sciences Consumer Health Database Health & Medical Collection (Alumni Edition) Healthcare Administration Database PML(ProQuest Medical Library) Psychology Database ProQuest Research Library ProQuest Science Database (NC LIVE) Algology Mycology and Protozoology Abstracts (Microbiology C) Biological Science Database Research Library (Corporate) Nursing & Allied Health Premium ProQuest Central Premium ProQuest One Academic (New) ProQuest Health & Medical Research Collection ProQuest One Academic Middle East (New) One Health & Nursing ProQuest One Academic Eastern Edition (DO NOT USE) One Applied & Life Sciences ProQuest One Academic (retired) ProQuest One Academic UKI Edition One Psychology ProQuest Central Basic SIRS Editorial MEDLINE - Academic SwePub SwePub Articles SWEPUB Göteborgs universitet |
| DatabaseTitle | CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) ProQuest One Psychology Research Library Prep ProQuest Central Student ProQuest Central Essentials Lancet Titles elibrary ProQuest AP Science SciTech Premium Collection Environmental Sciences and Pollution Management ProQuest One Applied & Life Sciences ProQuest One Sustainability Health Research Premium Collection Natural Science Collection Health & Medical Research Collection Biological Science Collection ProQuest Central (New) ProQuest Medical Library (Alumni) ProQuest Newsstand Professional Virology and AIDS Abstracts ProQuest Science Journals (Alumni Edition) ProQuest Biological Science Collection ProQuest Family Health ProQuest One Academic Eastern Edition ProQuest Hospital Collection Health Research Premium Collection (Alumni) Biological Science Database Neurosciences Abstracts ProQuest Hospital Collection (Alumni) Nursing & Allied Health Premium ProQuest Health & Medical Complete ProQuest One Academic UKI Edition ProQuest Health Management (Alumni Edition) ProQuest Nursing & Allied Health Source (Alumni) ProQuest One Academic Calcium & Calcified Tissue Abstracts ProQuest One Academic (New) ProQuest One Academic Middle East (New) SIRS Editorial ProQuest Health & Medical Complete (Alumni) ProQuest Central (Alumni Edition) ProQuest One Community College ProQuest One Health & Nursing Research Library (Alumni Edition) ProQuest Natural Science Collection ProQuest Pharma Collection ProQuest Family Health (Alumni Edition) ProQuest Biology Journals (Alumni Edition) ProQuest Central ProQuest Health & Medical Research Collection Health and Medicine Complete (Alumni Edition) ProQuest Central Korea Bacteriology Abstracts (Microbiology B) Algology Mycology and Protozoology Abstracts (Microbiology C) AIDS and Cancer Research Abstracts ProQuest Research Library ProQuest Public Health ProQuest Central Basic Toxicology Abstracts ProQuest Science Journals British Nursing Index with Full Text ProQuest Health Management British Nursing Index ProQuest Nursing & Allied Health Source ProQuest Psychology Journals (Alumni) ProQuest SciTech Collection ProQuest Medical Library ProQuest Psychology Journals ProQuest Central (Alumni) MEDLINE - Academic |
| DatabaseTitleList | ProQuest One Psychology MEDLINE - Academic MEDLINE |
| Database_xml | – sequence: 1 dbid: NPM name: PubMed url: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: BENPR name: ProQuest Central url: https://www.proquest.com/central sourceTypes: Aggregation Database |
| DeliveryMethod | fulltext_linktorsrc |
| Discipline | Medicine Public Health |
| EISSN | 1474-547X |
| EndPage | 2248 |
| ExternalDocumentID | oai_gup_ub_gu_se_324382 36423648 10_1016_S0140_6736_22_02185_7 S0140673622021857 |
| Genre | Research Support, Non-U.S. Gov't Journal Article |
| GeographicLocations | Africa South of the Sahara United States--US |
| GeographicLocations_xml | – name: Africa South of the Sahara – name: United States--US |
| GrantInformation | Bill & Melinda Gates Foundation, Wellcome Trust, and Department of Health and Social Care, using UK aid funding managed by the Fleming Fund. |
| GrantInformation_xml | – fundername: Medical Research Council grantid: MR/W020653/1 – fundername: Wellcome Trust – fundername: NIAID NIH HHS grantid: T32 AI007044 – fundername: NIGMS NIH HHS grantid: K23 GM141463 – fundername: FIC NIH HHS grantid: D43 TW009763 |
| GroupedDBID | --- --K --M .1- .55 .CO .FO 0R~ 123 1B1 1P~ 1RT 1~5 29L 4.4 457 4G. 53G 5VS 7-5 71M 7RV 7X7 88E 88I 8AF 8AO 8C1 8C2 8FE 8FH 8FI 8FJ 8G5 9JM AABNK AAEDT AAEDW AAFWJ AAIKJ AAKOC AALRI AAMRU AAQFI AATTM AAXKI AAXUO AAYWO ABBQC ABCQX ABFNM ABIVO ABJNI ABLJU ABMAC ABMZM ABOCM ABUFD ABUWG ACGFS ACGOD ACIEU ACIUM ACLOT ACPRK ACRLP ACVFH ADBBV ADCNI AEIPS AEKER AENEX AEUPX AEUYN AEVXI AFKRA AFPUW AFRAH AFRHN AFTJW AFXIZ AGAPS AGHFR AHMBA AIGII AIIUN AITUG AJRQY AJUYK AKBMS AKRWK AKYEP ALMA_UNASSIGNED_HOLDINGS AMRAJ AN0 ANZVX APXCP AQUVI AXJTR AZQEC BBNVY BCU BEC BENPR BHPHI BKEYQ BKNYI BKOJK BKOMP BNPGV BNQBC BPHCQ BVXVI CCPQU CS3 DU5 DWQXO EAU EBS EFJIC EFKBS EO8 EO9 EP2 EP3 EWM EX3 F5P FD8 FDB FIRID FNPLU FYGXN FYUFA G-2 G-Q GBLVA GNUQQ GUQSH HCIFZ HMCUK IHE J1W K-O K9- KOM L7B LK8 LZ2 M0R M0T M1P M2M M2O M2P M7P MJL MO0 N9A NAPCQ O-L O9- OD. OO~ OZT P-8 P-9 P2P PC. PHGZM PHGZT PJZUB PPXIY PQGLB PQQKQ PRG PROAC PSQYO PSYQQ ROL RPZ S0X SAD SDG SEL SES SJFOW SJN SPCBC SSH SSZ T5K TLN TWZ UAP UBE UKHRP UV1 WOW X7M XAX XDU YYM Z5R ZMT ~HD 6I. AACTN AAFTH AFCTW ALIPV M41 .GJ 04C 3EH 3O- 41~ 8WZ 9DU A6W AAEJM AAKAS AAQQT AAQXK AAYXX ABDBF ABWVN ACRPL ACUHS ADMUD ADNMO ADXHL ADZCM AFFHD AFFNX AGQPQ AHHHB AHQJS AJJEV AKVCP ARTTT ASPBG AVWKF AZFZN CITATION D0S EAP EAS EAZ EBC EBD EBU EGS EHN EIHBH EJD EMB EMK EMOBN ENC EPL EPS EPT ESX EVS FEDTE FGOYB HVGLF HZ~ J5H MVM OVD Q~Q R2- SV3 TEORI TH9 UHU UQL WOQ WUQ XPP YYQ ZGI ZXP ZY4 ~G0 AGCQF AGRNS CGR CUY CVF ECM EIF NPM 3V. 7QL 7QP 7TK 7U7 7U9 7XB 88A 8FK ASE C1K FPQ H94 K6X K9. KB~ M7N MBDVC PKEHL PQEST PQUKI Q9U 7X8 ADTPV AOWAS F1U |
| ID | FETCH-LOGICAL-c561t-7de33d97d3f3313ecde4b80f8b60caa60a6c9713e68c1178db3e2aec0f3111483 |
| IEDL.DBID | M2P |
| ISICitedReferencesCount | 1245 |
| ISICitedReferencesURI | http://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=Summon&SrcAuth=ProQuest&DestLinkType=CitingArticles&DestApp=WOS_CPL&KeyUT=000928263900001&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D |
| ISSN | 0140-6736 1474-547X |
| IngestDate | Tue Nov 04 16:20:32 EST 2025 Sun Nov 09 09:29:41 EST 2025 Tue Oct 07 07:46:09 EDT 2025 Mon Jul 21 06:08:10 EDT 2025 Sat Nov 29 07:25:11 EST 2025 Tue Nov 18 21:23:03 EST 2025 Sun Apr 06 06:53:30 EDT 2025 Tue Oct 14 19:30:50 EDT 2025 |
| IsDoiOpenAccess | true |
| IsOpenAccess | true |
| IsPeerReviewed | true |
| IsScholarly | true |
| Issue | 10369 |
| Language | English |
| License | This is an open access article under the CC BY license. Copyright © 2022 The Author(s). Published by Elsevier Ltd. This is an Open Access article under the CC BY 4.0 license. Published by Elsevier Ltd.. All rights reserved. |
| LinkModel | DirectLink |
| MergedId | FETCHMERGED-LOGICAL-c561t-7de33d97d3f3313ecde4b80f8b60caa60a6c9713e68c1178db3e2aec0f3111483 |
| Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 14 content type line 23 |
| OpenAccessLink | https://dx.doi.org/10.1016/S0140-6736(22)02185-7 |
| PMID | 36423648 |
| PQID | 2754830863 |
| PQPubID | 40246 |
| PageCount | 28 |
| ParticipantIDs | swepub_primary_oai_gup_ub_gu_se_324382 proquest_miscellaneous_2740514023 proquest_journals_2754830863 pubmed_primary_36423648 crossref_primary_10_1016_S0140_6736_22_02185_7 crossref_citationtrail_10_1016_S0140_6736_22_02185_7 elsevier_sciencedirect_doi_10_1016_S0140_6736_22_02185_7 elsevier_clinicalkey_doi_10_1016_S0140_6736_22_02185_7 |
| PublicationCentury | 2000 |
| PublicationDate | 2022-12-17 |
| PublicationDateYYYYMMDD | 2022-12-17 |
| PublicationDate_xml | – month: 12 year: 2022 text: 2022-12-17 day: 17 |
| PublicationDecade | 2020 |
| PublicationPlace | England |
| PublicationPlace_xml | – name: England – name: London |
| PublicationTitle | The Lancet (British edition) |
| PublicationTitleAlternate | Lancet |
| PublicationYear | 2022 |
| Publisher | Elsevier Ltd Elsevier Limited |
| Publisher_xml | – name: Elsevier Ltd – name: Elsevier Limited |
| References | (bib25) 2022; 399 Valentine, Solar, Irwin, Nolen, Prasad (bib5) 2008 Tacconelli (bib27) bib36 Jacobs, Hardy, Semret (bib57) 2019; 6 (bib47) 2020 Head, Brown, Newell, Scott, Batchelor, Atun (bib30) 2020; 8 Stevens, Alkema, Black (bib22) 2016; 13 Lynch, Zhanel (bib10) 2009; 30 Laxminarayan, Van Boeckel, Frost (bib44) 2020; 20 (bib24) 2020 Kelesidis, Falagas (bib42) 2015; 28 Do, Vu, Nguyen (bib43) 2021; 9 Burke (bib31) 2003; 348 bib45 Freeman, Stocks, Cumming (bib32) 2014; 19 Seymour, Gesten, Prescott (bib12) 2017; 376 Wolf, Prüss-Ustün, Cumming (bib33) 2014; 19 Yadav, Shah, Sayed, Horton, Schroeder (bib51) 2021; 9 bib7 Luby, Agboatwalla, Feikin (bib8) 2005; 366 Sartelli, Chichom-Mefire, Labricciosa (bib48) 2017; 12 Rudd, Johnson, Agesa (bib4) 2020; 395 bib39 bib1 bib2 O'Brien, Wolfson, Watt (bib13) 2009; 374 Alkire, Raykar, Shrime (bib49) 2015; 3 Wen, Ezure, Rolley (bib53) 2021; 18 Holmer, Lantz, Kunjumen (bib50) 2015; 3 Thigpen, Whitney, Messonnier (bib14) 2011; 364 Singer, Deutschman, Seymour (bib37) 2016; 315 bib15 bib54 bib55 Lim, Ashley, Hamers (bib56) 2021; 27 bib52 Page, McKenzie, Bossuyt (bib21) 2021; 372 (bib46) 2020 Araya, Hug, Joy, Oschmann, Rubinstein (bib40) (bib3) 2020; 396 (bib28) 2014 Nakaya, Bruna-Romero (bib35) 2015; 14 Ledesma, Ma, Vongpradith (bib29) 2022; 22 Nocedal, Wright (bib23) 2006 (bib6) 2017; 390 Evans, Rhodes, Alhazzani (bib11) 2021; 49 Allegranzi, Bischoff, de Jonge (bib26) 2016; 16 Smith, Huber (bib34) 2018; 31 bib20 bib18 bib17 (bib19) 2022; 399 Wahl, O'Brien, Greenbaum (bib16) 2018; 6 Poolman (bib9) 2020; 5 Frost, Craig, Joshi, Faure, Laxminarayan (bib41) 2019 Miethke, Pieroni, Weber (bib38) 2021; 5 Luby (10.1016/S0140-6736(22)02185-7_bib8) 2005; 366 Laxminarayan (10.1016/S0140-6736(22)02185-7_bib44) 2020; 20 (10.1016/S0140-6736(22)02185-7_bib47) 2020 Sartelli (10.1016/S0140-6736(22)02185-7_bib48) 2017; 12 Valentine (10.1016/S0140-6736(22)02185-7_bib5) 2008 Evans (10.1016/S0140-6736(22)02185-7_bib11) 2021; 49 Seymour (10.1016/S0140-6736(22)02185-7_bib12) 2017; 376 (10.1016/S0140-6736(22)02185-7_bib24) 2020 (10.1016/S0140-6736(22)02185-7_bib3) 2020; 396 Wahl (10.1016/S0140-6736(22)02185-7_bib16) 2018; 6 Page (10.1016/S0140-6736(22)02185-7_bib21) 2021; 372 (10.1016/S0140-6736(22)02185-7_bib28) 2014 Miethke (10.1016/S0140-6736(22)02185-7_bib38) 2021; 5 Nocedal (10.1016/S0140-6736(22)02185-7_bib23) 2006 (10.1016/S0140-6736(22)02185-7_bib19) 2022; 399 Ledesma (10.1016/S0140-6736(22)02185-7_bib29) 2022; 22 Lim (10.1016/S0140-6736(22)02185-7_bib56) 2021; 27 Nakaya (10.1016/S0140-6736(22)02185-7_bib35) 2015; 14 (10.1016/S0140-6736(22)02185-7_bib25) 2022; 399 Holmer (10.1016/S0140-6736(22)02185-7_bib50) 2015; 3 Smith (10.1016/S0140-6736(22)02185-7_bib34) 2018; 31 Freeman (10.1016/S0140-6736(22)02185-7_bib32) 2014; 19 Alkire (10.1016/S0140-6736(22)02185-7_bib49) 2015; 3 Yadav (10.1016/S0140-6736(22)02185-7_bib51) 2021; 9 (10.1016/S0140-6736(22)02185-7_bib46) 2020 (10.1016/S0140-6736(22)02185-7_bib6) 2017; 390 Wolf (10.1016/S0140-6736(22)02185-7_bib33) 2014; 19 Wen (10.1016/S0140-6736(22)02185-7_bib53) 2021; 18 Do (10.1016/S0140-6736(22)02185-7_bib43) 2021; 9 Frost (10.1016/S0140-6736(22)02185-7_bib41) 2019 Rudd (10.1016/S0140-6736(22)02185-7_bib4) 2020; 395 Allegranzi (10.1016/S0140-6736(22)02185-7_bib26) 2016; 16 Kelesidis (10.1016/S0140-6736(22)02185-7_bib42) 2015; 28 Tacconelli (10.1016/S0140-6736(22)02185-7_bib27) Araya (10.1016/S0140-6736(22)02185-7_bib40) Jacobs (10.1016/S0140-6736(22)02185-7_bib57) 2019; 6 Lynch (10.1016/S0140-6736(22)02185-7_bib10) 2009; 30 Head (10.1016/S0140-6736(22)02185-7_bib30) 2020; 8 O'Brien (10.1016/S0140-6736(22)02185-7_bib13) 2009; 374 Thigpen (10.1016/S0140-6736(22)02185-7_bib14) 2011; 364 Poolman (10.1016/S0140-6736(22)02185-7_bib9) 2020; 5 Stevens (10.1016/S0140-6736(22)02185-7_bib22) 2016; 13 Burke (10.1016/S0140-6736(22)02185-7_bib31) 2003; 348 Singer (10.1016/S0140-6736(22)02185-7_bib37) 2016; 315 36528366 - Lancet. 2023 Dec 17;400(10369):2161-2163. doi: 10.1016/S0140-6736(22)02424-2. |
| References_xml | – volume: 18 start-page: e1003787 year: 2021 ident: bib53 article-title: Gram-negative neonatal sepsis in low- and lower-middle-income countries and WHO empirical antibiotic recommendations: a systematic review and meta-analysis publication-title: PLoS Med – volume: 28 start-page: 443 year: 2015 end-page: 464 ident: bib42 article-title: Substandard/counterfeit antimicrobial drugs publication-title: Clin Microbiol Rev – volume: 9 start-page: e610 year: 2021 end-page: e619 ident: bib43 article-title: Community-based antibiotic access and use in six low-income and middle-income countries: a mixed-method approach publication-title: Lancet Glob Health – ident: bib15 article-title: GBS Surveillance Report 2019. Centers for Disease Control and Prevention, 2019 – volume: 399 start-page: 629 year: 2022 end-page: 655 ident: bib19 article-title: Global burden of bacterial antimicrobial resistance in 2019: a systematic analysis publication-title: Lancet – year: 2008 ident: bib5 publication-title: Health equity at the country level: building capacities and momentum for action. A report on the country stream of work in the commission on social determinants of health – volume: 396 start-page: 1204 year: 2020 end-page: 1222 ident: bib3 article-title: Global burden of 369 diseases and injuries in 204 countries and territories, 1990–2019: a systematic analysis for the Global Burden of Disease Study 2019 publication-title: Lancet – volume: 14 start-page: 777 year: 2015 end-page: 779 ident: bib35 article-title: Is the gut microbiome key to modulating vaccine efficacy? publication-title: Expert Rev Vaccines – volume: 19 start-page: 906 year: 2014 end-page: 916 ident: bib32 article-title: Hygiene and health: systematic review of handwashing practices worldwide and update of health effects publication-title: Trop Med Int Health – volume: 27 start-page: 1391 year: 2021 end-page: 1399 ident: bib56 article-title: Surveillance strategies using routine microbiology for antimicrobial resistance in low- and middle-income countries publication-title: Clin Microbiol Infect – year: 2020 ident: bib47 publication-title: Global report on the epidemiology and burden of sepsis: current evidence, identifying gaps and future directions – ident: bib2 article-title: Millennium Development Goals – ident: bib7 article-title: Department of Economic and Social Affairs. The 17 goals – volume: 315 start-page: 801 year: 2016 end-page: 810 ident: bib37 article-title: The third international consensus definitions for sepsis and septic shock (sepsis-3) publication-title: JAMA – volume: 364 start-page: 2016 year: 2011 end-page: 2025 ident: bib14 article-title: Bacterial meningitis in the United States, 1998–2007 publication-title: N Engl J Med – year: 2014 ident: bib28 publication-title: Antimicrobial resistance: global report on surveillance – ident: bib39 article-title: World development indicators. 2021 – volume: 5 start-page: 84 year: 2020 ident: bib9 article-title: Expanding the role of bacterial vaccines into life-course vaccination strategies and prevention of antimicrobial-resistant infections publication-title: NPJ Vaccines – ident: bib36 article-title: Surviving sepsis campaign 2021 adult guidelines – ident: bib54 article-title: WHO antibiotic categorization. Geneva: World Health Organization – year: 2020 ident: bib46 publication-title: Sepsis – volume: 374 start-page: 893 year: 2009 end-page: 902 ident: bib13 article-title: Burden of disease caused by publication-title: Lancet – ident: bib40 article-title: The impact of water and sanitation on diarrhoeal disease burden and over-consumption of antibiotics. London School of Economics and Political Science, March, 2016 – volume: 372 start-page: n71 year: 2021 ident: bib21 article-title: The PRISMA 2020 statement: an updated guideline for reporting systematic reviews publication-title: BMJ – volume: 30 start-page: 189 year: 2009 end-page: 209 ident: bib10 article-title: Streptococcus pneumoniae: epidemiology, risk factors, and strategies for prevention publication-title: Semin Respir Crit Care Med – volume: 13 start-page: e1002056 year: 2016 ident: bib22 article-title: Guidelines for Accurate and Transparent Health Estimates Reporting: the GATHER statement publication-title: PLoS Med – volume: 390 start-page: 1151 year: 2017 end-page: 1210 ident: bib6 article-title: Global, regional, and national age-sex specific mortality for 264 causes of death, 1980–2016: a systematic analysis for the Global Burden of Disease Study 2016 publication-title: Lancet – volume: 49 start-page: 1974 year: 2021 end-page: 1982 ident: bib11 article-title: Executive summary: surviving sepsis campaign: international guidelines for the management of sepsis and septic shock 2021 publication-title: Crit Care Med – volume: 366 start-page: 225 year: 2005 end-page: 233 ident: bib8 article-title: Effect of handwashing on child health: a randomised controlled trial publication-title: Lancet – ident: bib52 article-title: WHO model list of essential medicines - 22nd list, 2021. Geneva: World Health Organization, Sept 30, 2021 – volume: 20 start-page: e51 year: 2020 end-page: e60 ident: bib44 article-title: The publication-title: Lancet Infect Dis – volume: 6 start-page: 205 year: 2019 ident: bib57 article-title: Diagnostic bacteriology in district hospitals in sub-Saharan Africa: at the forefront of the containment of antimicrobial resistance publication-title: Front Med (Lausanne) – volume: 9 start-page: e1553 year: 2021 end-page: e1560 ident: bib51 article-title: Availability of essential diagnostics in ten low-income and middle-income countries: results from national health facility surveys publication-title: Lancet Glob Health – ident: bib27 article-title: Global priority list of antibiotic-resistant bacteria to guide research, discovery, and development of new antibiotics. World Health Organization, 2017 – ident: bib45 article-title: Ending preventable child deaths from pneumonia and diarrhoea by 2025: the integrated Global Action Plan for Pneumonia and Diarrhoea (GAPPD). 2013 – ident: bib17 article-title: Active Bacterial Core surveillance (ABCs). July 19, 2021 – year: 2020 ident: bib24 publication-title: Immunization agenda 2030: a global strategy to leave no one behind – volume: 399 start-page: 335 year: 2022 ident: bib25 article-title: Antimicrobial resistance: time to repurpose the Global Fund publication-title: Lancet – year: 2006 ident: bib23 publication-title: Numerical optimization, second edition – volume: 16 start-page: e276 year: 2016 end-page: e287 ident: bib26 article-title: New WHO recommendations on preoperative measures for surgical site infection prevention: an evidence-based global perspective publication-title: Lancet Infect Dis – volume: 376 start-page: 2235 year: 2017 end-page: 2244 ident: bib12 article-title: Time to treatment and mortality during mandated emergency care for sepsis publication-title: N Engl J Med – volume: 8 start-page: e1295 year: 2020 end-page: e1304 ident: bib30 article-title: The allocation of US$105 billion in global funding from G20 countries for infectious disease research between 2000 and 2017: a content analysis of investments publication-title: Lancet Glob Health – volume: 395 start-page: 200 year: 2020 end-page: 211 ident: bib4 article-title: Global, regional, and national sepsis incidence and mortality, 1990–2017: analysis for the Global Burden of Disease Study publication-title: Lancet – volume: 3 start-page: S9 year: 2015 end-page: 11 ident: bib50 article-title: Global distribution of surgeons, anaesthesiologists, and obstetricians publication-title: Lancet Glob Health – volume: 3 start-page: e316 year: 2015 end-page: e323 ident: bib49 article-title: Global access to surgical care: a modelling study publication-title: Lancet Glob Health – ident: bib18 article-title: European Antimicrobial Resistance Surveillance Network (EARS-Net) – volume: 31 start-page: 159 year: 2018 end-page: 173 ident: bib34 article-title: The unexpected impact of vaccines on secondary bacterial infections following influenza publication-title: Viral Immunol – volume: 19 start-page: 928 year: 2014 end-page: 942 ident: bib33 article-title: Assessing the impact of drinking water and sanitation on diarrhoeal disease in low- and middle-income settings: systematic review and meta-regression publication-title: Trop Med Int Health – volume: 348 start-page: 651 year: 2003 end-page: 656 ident: bib31 article-title: Infection control - a problem for patient safety publication-title: N Engl J Med – ident: bib55 article-title: Global tuberculosis report 2020. Geneva: World Health Organization, Oct 15, 2020 – volume: 12 start-page: 29 year: 2017 ident: bib48 article-title: The management of intra-abdominal infections from a global perspective: 2017 WSES guidelines for management of intra-abdominal infections publication-title: World J Emerg Surg – ident: bib20 article-title: Protocol for the Global Burden of Diseases, Injuries, and Risk Factors Study (GBD), version 4.0. March, 2020 – ident: bib1 article-title: Sustainable Development Goals – year: 2019 ident: bib41 publication-title: Access barriers to antibiotics – volume: 5 start-page: 726 year: 2021 end-page: 749 ident: bib38 article-title: Towards the sustainable discovery and development of new antibiotics publication-title: Nat Rev Chem – volume: 6 start-page: e744 year: 2018 end-page: e757 ident: bib16 article-title: Burden of Streptococcus pneumoniae and Haemophilus influenzae type b disease in children in the era of conjugate vaccines: global, regional, and national estimates for 2000–15 publication-title: Lancet Glob Health – volume: 22 start-page: 222 year: 2022 end-page: 241 ident: bib29 article-title: Global, regional, and national sex differences in the global burden of tuberculosis by HIV status, 1990–2019: results from the Global Burden of Disease Study 2019 publication-title: Lancet Infect Dis – volume: 372 start-page: n71 year: 2021 ident: 10.1016/S0140-6736(22)02185-7_bib21 article-title: The PRISMA 2020 statement: an updated guideline for reporting systematic reviews publication-title: BMJ doi: 10.1136/bmj.n71 – volume: 16 start-page: e276 year: 2016 ident: 10.1016/S0140-6736(22)02185-7_bib26 article-title: New WHO recommendations on preoperative measures for surgical site infection prevention: an evidence-based global perspective publication-title: Lancet Infect Dis doi: 10.1016/S1473-3099(16)30398-X – volume: 374 start-page: 893 year: 2009 ident: 10.1016/S0140-6736(22)02185-7_bib13 article-title: Burden of disease caused by Streptococcus pneumoniae in children younger than 5 years: global estimates publication-title: Lancet doi: 10.1016/S0140-6736(09)61204-6 – volume: 8 start-page: e1295 year: 2020 ident: 10.1016/S0140-6736(22)02185-7_bib30 article-title: The allocation of US$105 billion in global funding from G20 countries for infectious disease research between 2000 and 2017: a content analysis of investments publication-title: Lancet Glob Health doi: 10.1016/S2214-109X(20)30357-0 – volume: 19 start-page: 928 year: 2014 ident: 10.1016/S0140-6736(22)02185-7_bib33 article-title: Assessing the impact of drinking water and sanitation on diarrhoeal disease in low- and middle-income settings: systematic review and meta-regression publication-title: Trop Med Int Health doi: 10.1111/tmi.12331 – volume: 18 start-page: e1003787 year: 2021 ident: 10.1016/S0140-6736(22)02185-7_bib53 article-title: Gram-negative neonatal sepsis in low- and lower-middle-income countries and WHO empirical antibiotic recommendations: a systematic review and meta-analysis publication-title: PLoS Med doi: 10.1371/journal.pmed.1003787 – ident: 10.1016/S0140-6736(22)02185-7_bib40 – year: 2008 ident: 10.1016/S0140-6736(22)02185-7_bib5 – volume: 390 start-page: 1151 year: 2017 ident: 10.1016/S0140-6736(22)02185-7_bib6 article-title: Global, regional, and national age-sex specific mortality for 264 causes of death, 1980–2016: a systematic analysis for the Global Burden of Disease Study 2016 publication-title: Lancet doi: 10.1016/S0140-6736(17)32152-9 – volume: 9 start-page: e610 year: 2021 ident: 10.1016/S0140-6736(22)02185-7_bib43 article-title: Community-based antibiotic access and use in six low-income and middle-income countries: a mixed-method approach publication-title: Lancet Glob Health doi: 10.1016/S2214-109X(21)00024-3 – volume: 366 start-page: 225 year: 2005 ident: 10.1016/S0140-6736(22)02185-7_bib8 article-title: Effect of handwashing on child health: a randomised controlled trial publication-title: Lancet doi: 10.1016/S0140-6736(05)66912-7 – volume: 6 start-page: 205 year: 2019 ident: 10.1016/S0140-6736(22)02185-7_bib57 article-title: Diagnostic bacteriology in district hospitals in sub-Saharan Africa: at the forefront of the containment of antimicrobial resistance publication-title: Front Med (Lausanne) doi: 10.3389/fmed.2019.00205 – year: 2020 ident: 10.1016/S0140-6736(22)02185-7_bib47 – volume: 396 start-page: 1204 year: 2020 ident: 10.1016/S0140-6736(22)02185-7_bib3 article-title: Global burden of 369 diseases and injuries in 204 countries and territories, 1990–2019: a systematic analysis for the Global Burden of Disease Study 2019 publication-title: Lancet doi: 10.1016/S0140-6736(20)30925-9 – volume: 13 start-page: e1002056 year: 2016 ident: 10.1016/S0140-6736(22)02185-7_bib22 article-title: Guidelines for Accurate and Transparent Health Estimates Reporting: the GATHER statement publication-title: PLoS Med doi: 10.1371/journal.pmed.1002056 – volume: 28 start-page: 443 year: 2015 ident: 10.1016/S0140-6736(22)02185-7_bib42 article-title: Substandard/counterfeit antimicrobial drugs publication-title: Clin Microbiol Rev doi: 10.1128/CMR.00072-14 – volume: 364 start-page: 2016 year: 2011 ident: 10.1016/S0140-6736(22)02185-7_bib14 article-title: Bacterial meningitis in the United States, 1998–2007 publication-title: N Engl J Med doi: 10.1056/NEJMoa1005384 – volume: 12 start-page: 29 year: 2017 ident: 10.1016/S0140-6736(22)02185-7_bib48 article-title: The management of intra-abdominal infections from a global perspective: 2017 WSES guidelines for management of intra-abdominal infections publication-title: World J Emerg Surg doi: 10.1186/s13017-017-0141-6 – volume: 376 start-page: 2235 year: 2017 ident: 10.1016/S0140-6736(22)02185-7_bib12 article-title: Time to treatment and mortality during mandated emergency care for sepsis publication-title: N Engl J Med doi: 10.1056/NEJMoa1703058 – volume: 399 start-page: 335 year: 2022 ident: 10.1016/S0140-6736(22)02185-7_bib25 article-title: Antimicrobial resistance: time to repurpose the Global Fund publication-title: Lancet doi: 10.1016/S0140-6736(22)00091-5 – volume: 49 start-page: 1974 year: 2021 ident: 10.1016/S0140-6736(22)02185-7_bib11 article-title: Executive summary: surviving sepsis campaign: international guidelines for the management of sepsis and septic shock 2021 publication-title: Crit Care Med doi: 10.1097/CCM.0000000000005357 – volume: 5 start-page: 84 year: 2020 ident: 10.1016/S0140-6736(22)02185-7_bib9 article-title: Expanding the role of bacterial vaccines into life-course vaccination strategies and prevention of antimicrobial-resistant infections publication-title: NPJ Vaccines doi: 10.1038/s41541-020-00232-0 – year: 2014 ident: 10.1016/S0140-6736(22)02185-7_bib28 – volume: 3 start-page: e316 year: 2015 ident: 10.1016/S0140-6736(22)02185-7_bib49 article-title: Global access to surgical care: a modelling study publication-title: Lancet Glob Health doi: 10.1016/S2214-109X(15)70115-4 – volume: 19 start-page: 906 year: 2014 ident: 10.1016/S0140-6736(22)02185-7_bib32 article-title: Hygiene and health: systematic review of handwashing practices worldwide and update of health effects publication-title: Trop Med Int Health doi: 10.1111/tmi.12339 – year: 2020 ident: 10.1016/S0140-6736(22)02185-7_bib46 – year: 2019 ident: 10.1016/S0140-6736(22)02185-7_bib41 – volume: 6 start-page: e744 year: 2018 ident: 10.1016/S0140-6736(22)02185-7_bib16 article-title: Burden of Streptococcus pneumoniae and Haemophilus influenzae type b disease in children in the era of conjugate vaccines: global, regional, and national estimates for 2000–15 publication-title: Lancet Glob Health doi: 10.1016/S2214-109X(18)30247-X – volume: 27 start-page: 1391 year: 2021 ident: 10.1016/S0140-6736(22)02185-7_bib56 article-title: Surveillance strategies using routine microbiology for antimicrobial resistance in low- and middle-income countries publication-title: Clin Microbiol Infect doi: 10.1016/j.cmi.2021.05.037 – volume: 20 start-page: e51 year: 2020 ident: 10.1016/S0140-6736(22)02185-7_bib44 article-title: The Lancet Infectious Diseases Commission on antimicrobial resistance: 6 years later publication-title: Lancet Infect Dis doi: 10.1016/S1473-3099(20)30003-7 – volume: 315 start-page: 801 year: 2016 ident: 10.1016/S0140-6736(22)02185-7_bib37 article-title: The third international consensus definitions for sepsis and septic shock (sepsis-3) publication-title: JAMA doi: 10.1001/jama.2016.0287 – year: 2020 ident: 10.1016/S0140-6736(22)02185-7_bib24 – year: 2006 ident: 10.1016/S0140-6736(22)02185-7_bib23 – volume: 30 start-page: 189 year: 2009 ident: 10.1016/S0140-6736(22)02185-7_bib10 article-title: Streptococcus pneumoniae: epidemiology, risk factors, and strategies for prevention publication-title: Semin Respir Crit Care Med doi: 10.1055/s-0029-1202938 – volume: 9 start-page: e1553 year: 2021 ident: 10.1016/S0140-6736(22)02185-7_bib51 article-title: Availability of essential diagnostics in ten low-income and middle-income countries: results from national health facility surveys publication-title: Lancet Glob Health doi: 10.1016/S2214-109X(21)00442-3 – volume: 399 start-page: 629 year: 2022 ident: 10.1016/S0140-6736(22)02185-7_bib19 article-title: Global burden of bacterial antimicrobial resistance in 2019: a systematic analysis publication-title: Lancet doi: 10.1016/S0140-6736(21)02724-0 – ident: 10.1016/S0140-6736(22)02185-7_bib27 – volume: 31 start-page: 159 year: 2018 ident: 10.1016/S0140-6736(22)02185-7_bib34 article-title: The unexpected impact of vaccines on secondary bacterial infections following influenza publication-title: Viral Immunol doi: 10.1089/vim.2017.0138 – volume: 348 start-page: 651 year: 2003 ident: 10.1016/S0140-6736(22)02185-7_bib31 article-title: Infection control - a problem for patient safety publication-title: N Engl J Med doi: 10.1056/NEJMhpr020557 – volume: 395 start-page: 200 year: 2020 ident: 10.1016/S0140-6736(22)02185-7_bib4 article-title: Global, regional, and national sepsis incidence and mortality, 1990–2017: analysis for the Global Burden of Disease Study publication-title: Lancet doi: 10.1016/S0140-6736(19)32989-7 – volume: 14 start-page: 777 year: 2015 ident: 10.1016/S0140-6736(22)02185-7_bib35 article-title: Is the gut microbiome key to modulating vaccine efficacy? publication-title: Expert Rev Vaccines doi: 10.1586/14760584.2015.1040395 – volume: 22 start-page: 222 year: 2022 ident: 10.1016/S0140-6736(22)02185-7_bib29 article-title: Global, regional, and national sex differences in the global burden of tuberculosis by HIV status, 1990–2019: results from the Global Burden of Disease Study 2019 publication-title: Lancet Infect Dis doi: 10.1016/S1473-3099(21)00449-7 – volume: 3 start-page: S9 issue: suppl 2 year: 2015 ident: 10.1016/S0140-6736(22)02185-7_bib50 article-title: Global distribution of surgeons, anaesthesiologists, and obstetricians publication-title: Lancet Glob Health doi: 10.1016/S2214-109X(14)70349-3 – volume: 5 start-page: 726 year: 2021 ident: 10.1016/S0140-6736(22)02185-7_bib38 article-title: Towards the sustainable discovery and development of new antibiotics publication-title: Nat Rev Chem doi: 10.1038/s41570-021-00313-1 – reference: 36528366 - Lancet. 2023 Dec 17;400(10369):2161-2163. doi: 10.1016/S0140-6736(22)02424-2. |
| SSID | ssj0004605 |
| Score | 2.7648864 |
| Snippet | Reducing the burden of death due to infection is an urgent global public health priority. Previous studies have estimated the number of deaths associated with... Summary Background Reducing the burden of death due to infection is an urgent global public health priority. Previous studies have estimated the number of... Background Reducing the burden of death due to infection is an urgent global public health priority. Previous studies have estimated the number of deaths... |
| SourceID | swepub proquest pubmed crossref elsevier |
| SourceType | Open Access Repository Aggregation Database Index Database Enrichment Source Publisher |
| StartPage | 2221 |
| SubjectTerms | Africa South of the Sahara Antibiotics Antimicrobial agents Antimicrobial resistance Bacteria Bacterial diseases Bacterial infections Bacterial Infections - epidemiology Charities Child children Clinical Medicine Death Disease control Disorders Drug resistance E coli Escherichia coli Estimates Fatalities Female Funding General & Internal Medicine Global Burden of Disease Global Health guidelines health Humans infections Infectious diseases Klebsiella Klebsiella pneumoniae Klinisk medicin Male management Mathematical analysis Microbiological analysis Mortality Pathogens Pseudomonas aeruginosa Public health Risk analysis Risk Factors Sepsis Staphylococcus aureus strategies Streptococcus pneumoniae Syndrome Vaccine development Vaccines |
| Title | Global mortality associated with 33 bacterial pathogens in 2019: a systematic analysis for the Global Burden of Disease Study 2019 |
| URI | https://www.clinicalkey.com/#!/content/1-s2.0-S0140673622021857 https://dx.doi.org/10.1016/S0140-6736(22)02185-7 https://www.ncbi.nlm.nih.gov/pubmed/36423648 https://www.proquest.com/docview/2754830863 https://www.proquest.com/docview/2740514023 https://gup.ub.gu.se/publication/324382 |
| Volume | 400 |
| WOSCitedRecordID | wos000928263900001&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D |
| hasFullText | 1 |
| inHoldings | 1 |
| isFullTextHit | |
| isPrint | |
| journalDatabaseRights | – providerCode: PRVPQU databaseName: Biological Science Database customDbUrl: eissn: 1474-547X dateEnd: 20250909 omitProxy: false ssIdentifier: ssj0004605 issn: 0140-6736 databaseCode: M7P dateStart: 19920104 isFulltext: true titleUrlDefault: http://search.proquest.com/biologicalscijournals providerName: ProQuest – providerCode: PRVPQU databaseName: Consumer Health Database customDbUrl: eissn: 1474-547X dateEnd: 20250909 omitProxy: false ssIdentifier: ssj0004605 issn: 0140-6736 databaseCode: M0R dateStart: 19920104 isFulltext: true titleUrlDefault: https://search.proquest.com/familyhealth providerName: ProQuest – providerCode: PRVPQU databaseName: Healthcare Administration Database customDbUrl: eissn: 1474-547X dateEnd: 20250909 omitProxy: false ssIdentifier: ssj0004605 issn: 0140-6736 databaseCode: M0T dateStart: 19920104 isFulltext: true titleUrlDefault: https://search.proquest.com/healthmanagement providerName: ProQuest – providerCode: PRVPQU databaseName: Nursing & Allied Health Database customDbUrl: eissn: 1474-547X dateEnd: 20250909 omitProxy: false ssIdentifier: ssj0004605 issn: 0140-6736 databaseCode: 7RV dateStart: 19920104 isFulltext: true titleUrlDefault: https://search.proquest.com/nahs providerName: ProQuest – providerCode: PRVPQU databaseName: ProQuest Central customDbUrl: eissn: 1474-547X dateEnd: 20250909 omitProxy: false ssIdentifier: ssj0004605 issn: 0140-6736 databaseCode: BENPR dateStart: 19920104 isFulltext: true titleUrlDefault: https://www.proquest.com/central providerName: ProQuest – providerCode: PRVPQU databaseName: ProQuest Health & Medical Collection customDbUrl: eissn: 1474-547X dateEnd: 20250909 omitProxy: false ssIdentifier: ssj0004605 issn: 0140-6736 databaseCode: 7X7 dateStart: 19920104 isFulltext: true titleUrlDefault: https://search.proquest.com/healthcomplete providerName: ProQuest – providerCode: PRVPQU databaseName: ProQuest Research Library customDbUrl: eissn: 1474-547X dateEnd: 20250909 omitProxy: false ssIdentifier: ssj0004605 issn: 0140-6736 databaseCode: M2O dateStart: 19920104 isFulltext: true titleUrlDefault: https://search.proquest.com/pqrl providerName: ProQuest – providerCode: PRVPQU databaseName: ProQuest Science Database (NC LIVE) customDbUrl: eissn: 1474-547X dateEnd: 20250909 omitProxy: false ssIdentifier: ssj0004605 issn: 0140-6736 databaseCode: M2P dateStart: 19920104 isFulltext: true titleUrlDefault: https://search.proquest.com/sciencejournals providerName: ProQuest – providerCode: PRVPQU databaseName: Psychology Database customDbUrl: eissn: 1474-547X dateEnd: 20250909 omitProxy: false ssIdentifier: ssj0004605 issn: 0140-6736 databaseCode: M2M dateStart: 19920104 isFulltext: true titleUrlDefault: https://www.proquest.com/psychology providerName: ProQuest – providerCode: PRVPQU databaseName: Public Health Database customDbUrl: eissn: 1474-547X dateEnd: 20250909 omitProxy: false ssIdentifier: ssj0004605 issn: 0140-6736 databaseCode: 8C1 dateStart: 19920104 isFulltext: true titleUrlDefault: https://search.proquest.com/publichealth providerName: ProQuest |
| link | http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV3ra9UwFA9uExHEx3xdnSOCiH6oa5PeJvGL6Nzwg_da5hz3W0iTdAy29rreK_jVv9yTR3tBpxOE9kAfJ7TN6Tm_JOeB0LNKj7nKKpFQXY-TXMA_J0zNkkJw7cqUK-Oj0o4-sumUz2aijBNuXXSr7HWiV9Sm1W6OfIcw4KQAwOmb-dfEVY1yq6uxhMYa2gBkkzmXrgkpL4qL9C7uqwienc_DyReEvHSGbpywP9mm37HnL4lFvTHav_W_r3Eb3YwwFL8NcnMHXbHNJro2iQvtm-hGmM7DIUrpLvoRagPgM4_WAbljFfvVGuzmcjGluAqZn-E2V-e4BdHs8EmDwfiL11jhVdJorGIqFAyQGQMExbH5EFSB2xq_DwtH2Pk5fvdN3ENf9vcOdz8ksXxDogGULRJmLKVGMENrSjNqtbF5xdOaV0WqlSpSVWgBY2RbcJ1ljJuKWqKsTmuauVEavY_Wm7axDxEWYxAggFJ1bqs8zwWHYZDRttBFVpjK8hHK-46TOuY2dyU2TuUFTmyESN_fko3Qq4FtHpJ7XMZQ9FIh-8hV0LUSzM9ljHxgjNAmQJZ_Yd3qJUlG_dLJlRiN0NPhMmgGt9yjGtsu3T25S24PoGyEHgSxHd6SwrATdvhwz4McD1dcuvHj5VzCqeOl7KwExE05efT3p3iMrhMXF5LBxrbQ-uJ8aZ-gq_rb4qQ730Zr7ODI0RnzlAPlu9k22ni3Ny0P4GiSBnroKJl4-snT0lFW_gRHKkGr |
| linkProvider | ProQuest |
| linkToHtml | http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMw1V3da9RAEB9qFRXEj1r1tOoIKvYh9rKbS3YFEbGWll6PglX6tm52N6Wgl7O5U_rqH-Tf6Gw2yYFW60sfhOQlySzJZj5-szsfAI9zMxA6zmXETTGIEkkyJ22RRakUxrcp17bOSvswzEYjsb8vdxfgR5sL48MqW51YK2pbGr9GvsYyouQEwPmryZfId43yu6ttC43AFtvu-Bu5bNXLrXX6v08Y23i792YzaroKRIawwjTKrOPcyszygvOYO2Ndkot-IfK0b7RO-zo1klw3lwoTx5mwOXdMO9MveOydB07jnoPzia8s5kMF2e5JeZh1SP08Y2jtXXfxGWOr3rAOouxPtvB3rPtLIdPa-G1c-9-m7TpcbWA2vg5ycQMW3HgJLu40gQRLcCUsV2LIwroJ30PvA_xceyPkmaBu-NZZ9GvVyDnmobI1Peb7OJckehUejpHAjXyBGudFsVE3pV6QXAIkiI3N8CFpBMsC18PGGPo4zuN6iGV4fyYzcgsWx-XY3QGUAxIQgopF4vIkSaQgN88al5o0Tm3uRA-SllGUaWq3-xYin9QJQXqMqZq_VNaD5x3ZJBQvOY0gbblQtZm5ZEsUmdfTCEVH2EC3AMn-hXSl5VzV6M9Kzdm2B4-626T5_HaWHrty5p9JfPF-Ap09uB3EpPtKTm41nTRxT4PcdHd8OfWD2UTRpYOZqpwij4ILdvfvb_EQLm3u7QzVcGu0fQ8uM58DE9ORrcDi9Gjm7sMF83V6WB09qDUCwsezlqWfcViVUg |
| linkToPdf | http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMw1V3da9UwFD_MKUMQP-bUq1MjqOhDvW3SNqkgIl4vjm2XoVP2lrVJOgbaXtd7lb36Z_nXedKkvaDT-bIHoX1pe0Kbno_fSc4HwMNCJSKPiixgqkyCOEOZy3TJgzQTyrYpz3WblfZxi08mYm8v21mCH10ujA2r7HRiq6h1rewa-ZBypGQIwNmw9GERO6Pxy-mXwHaQsjutXTsNxyKb5vgbum_Ni40R_utHlI7f7L5-G_gOA4FC3DALuDaM6YxrVjIWMaO0iQsRlqJIQ5XnaZinKkM3zqRCRREXumCG5kaFJYusI8Fw3HNwnscJtXX7t8N3J-VktuH1i-yh4fv-4hNKn1ojmwT8T3bxd9z7S1HT1hCOr_zPU3gVLnv4TV45ebkGS6ZahZVtH2CwCpfcMiZx2VnX4bvriUA-t14Keiwk9_xsNLFr2IQxUriK1_iY7e9co0g25LAiCHqy5yQni2LZJPclYAi6CgShN_HDu2QSUpdk5DbMiI3vPG6HWIMPZzIjN2C5qitzC0iWoOAghCxjU8RxnAl0_7QyqUqjVBdGDCDumEYqX9Pdthb5JE8I3qNUtrwm-QCe9WRTV9TkNIK040jZZeyijZFodk8jFD2hh3QOqv0L6XrHxdLr1UYuWHgAD_rbqBHtNldemXpun4ltUX8EowO46USm_0qG7jaeOHGPnQz1d2yZ9YP5VOKlg7lsjERPgwl6--9vcR9WUITk1sZk8w5cpDY1JsKDr8Py7Ghu7sIF9XV22Bzda5UDgf2zFqWfDfOeFQ |
| openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Global+mortality+associated+with+33+bacterial+pathogens+in+2019%3A+a+systematic+analysis+for+the+Global+Burden+of+Disease+Study+2019&rft.jtitle=The+Lancet+%28British+edition%29&rft.au=Davis+Weaver%2C+Nicole&rft.au=Abbasi-Kangevari%2C+Zeinab&rft.au=Acuna%2C+Juan+Manuel&rft.au=Aghdam%2C+Zahra+Babaei&rft.date=2022-12-17&rft.pub=Elsevier+Ltd&rft.issn=0140-6736&rft.volume=400&rft.issue=10369&rft.spage=2221&rft.epage=2248&rft_id=info:doi/10.1016%2FS0140-6736%2822%2902185-7&rft.externalDocID=S0140673622021857 |
| thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0140-6736&client=summon |
| thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0140-6736&client=summon |
| thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0140-6736&client=summon |